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ABSTRACT 
Louise Kathleen Fleming: Parental Management of Adrenal Crisis in 
Children with Congenital Adrenal Hyperplasia 
(Under the direction of Marcia Van Riper and Kathleen Knafl) 
 
Background: Life-threatening conditions in children change the meaning of 
parenting. Classical congenital adrenal hyperplasia (CAH), a rare, endocrine disorder, 
requires caregivers to inject a child with hydrocortisone intramuscularly during illness and 
adrenal crisis. The inability to effectively respond to a crisis prevents parents from optimally 
managing the condition. Few studies have examined parental education on managing crises 
or parental management strategies. Identifying gaps in parent education by healthcare 
providers, especially concerning times of crisis, is necessary to promote positive outcomes, 
for children and family members. 
Purpose: This is a three-manuscript dissertation. Chapter 2 presents a systematic 
review of the literature surrounding CAH management. Chapter 3 presents the results of a 
two-phase, mixed methods study examining parental management of adrenal crisis in 
children with CAH. Chapter 4 compares the family experiences of parents of girls versus 
boys with CAH. 
Methods: Chapter 2 is a systematic literature review examining the management 
and care related to children with CAH. Chapter 3 presents the results of a mixed methods 
study. In phase 1, parents completed online questionnaires about family life in the context of 
having a child with CAH. Results from Phase 1 were used to select a purposive sample for 
interviews in Phase 2 to elicit descriptions of parents’ experiences of managing CAH-related 
crises and their perceptions of the consequences of living with CAH. Chapter 4 compares 
the family experiences of parents of girls versus boys with CAH.  
				iv	
Results: Four distinct themes emerged from the literature regarding family 
management of CAH.  As parents’ management ability increases, CAH has less impact on 
the family.  Additionally, parents feel better able to manage the condition after their child 
turns 5 years old. Families having a daughter with CAH experience significant, additional 
challenges such as stigmatization, surgery, and disclosure about their daughter’s CAH.  
Conclusion:  Healthcare providers should deliver increased and more frequent 
education regarding adrenal crisis management and offer more in-depth, emotional 
assistance to parents of children with CAH. Furthermore, providers need to create a network 
of support specifically for families of girls born with CAH that addresses both surgical 
decisions and the stigmatization often associated with ambiguous genitalia.  
				v
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 INTRODUCTION 
Background and Significance 
Classic congenital adrenal hyperplasia (CAH) is a life-long, life threatening endocrine 
condition that has the potential to negatively affect the lives of children diagnosed with it as 
well as their families. CAH is inherited in an autosomal recessive pattern and affects 
approximately 1 in 15,000 live births (Speiser et al., 2010). Management of this condition 
requires parents to administer steroids, typically oral hydrocortisone, up to three times daily. 
In addition, parents need to supplement maintenance doses with oral “stress dosing” during 
times of illness and intramuscular (IM) injections of hydrocortisone when a child is unable to 
tolerate oral medications and/or if signs of adrenal crisis are present (Merke & Bornstein, 
2005, Speiser et al., 2010, Witchel & Azziz, 2011). Children with CAH are at significant risk 
for adrenal crisis, defined as an abrupt, life threatening state with symptoms including 
hypotension, pallor, fatigue, headache, tachycardia, and vomiting, due to glucocorticoid and 
mineralocorticoid deficiency (Speiser, 2011). The need for stress dosing, either orally or by 
injection, related to simple viral and bacterial childhood illnesses is frequent and 
unpredictable, requiring parents to make life or death complex treatment decisions (Merke & 
Bornstein, 2005). The looming threat of an adrenal crisis is ever present, and the knowledge 
that improperly responding to such a threat can result in a fatal outcome creates an 
environment of uncertainty, stress, and potential dysfunction within the family (Fleming, 
Rapp, & Sloane, 2011). 
Despite the importance of being able to effectively respond to an adrenal crisis 
episode, a 2011 study showed that only half of the 60 parents of children with CAH 
surveyed reported ever having received a demonstration from a health care professional on 
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how to administer the emergency injection of hydrocortisone (Fleming, Rapp, & Sloane, 
2011). Additionally, although these children experienced adrenal crisis one to two times per 
year, 39% of parents had not received a prescription for injectable hydrocortisone at the 
time of diagnosis, despite that being the standard of care (Speiser et al., 2010). The study 
further found that the type of emergency education given to parents by health care providers 
varied considerably, with some parents receiving no formal instruction from providers while 
others receiving both oral and written instruction as well as an actual injection demonstration 
from a provider on when and how and to correctly administer the injection (Fleming et al., 
2011). Adrenal crisis events are inherently stressful for parents and a lack of detailed, 
ongoing, thorough education from health care providers to parents on how to best handle 
such occurrences increases parental stress regarding ability to respond effectively in an 
emergency. 
CAH shares characteristics of episodic, life-threatening crises with other, more 
prevalent, chronic childhood conditions (Harris et. al, 2002; Barnard et. al., 2010; Sicherer 
et. al, 2010).  For example, during times of hypoglycemia in children with Type 1 diabetes, 
defined as a serum blood glucose level less than 70 mg/dL, parents are instructed to 
administer IM glucagon to prevent further declining blood glucose and the health hazards 
associated with hypoglycemia such as confusion, tachycardia, tremors, and even death 
(NIDDK, 2008). As with CAH, prior research in the pediatric diabetes community suggests 
that parental fear over their ability to properly handle times of a life threatening 
hypoglycemic crisis in their child is related to a lack of thorough and repeated education 
from health care providers (Harris et. al, 2002; Barnard et. al., 2010; Sullivan-Bolyai et. al, 
2010). In a descriptive study of parents of school-age children with diabetes who were 
attending a summer education camp, over half (69%) of parents reported experiencing 
hypoglycemic management difficulties, such as opening the IM injection kit and removing 
the needle and syringe. Moreover, approximately a fourth of the parents injected an 
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incorrect dose of glucagon during a simulation (Harris et. al, 2002). Parental stress is not 
only a challenge for parents of diabetic children, but can also negatively affect children’s 
health outcomes, as parents report maintaining slightly elevated blood glucose levels in their 
children in an effort to avoid hypoglycemia (Barnard et. al, 2010). 
Another childhood chronic condition that requires an IM injection during times of 
crisis is life threatening, or anaphylactic, food allergies, which affect approximately 5% of 
children--and that number is rising (Liu et al., 2010). Management of food allergies depends 
on strict allergen avoidance and ready availability of injectable epinephrine for emergency 
management (LeBovidge et al., 2008). Emergency IM epinephrine administration is crucial 
in managing anaphylaxis, but epinephrine auto-injectors (EAI) are underused by providers, 
patients, and their families (Chad et al., 2013). Studies have described a lack of parental 
knowledge regarding indications and technical aspects of EAI administration (Kapoor et al., 
2004; Hayman, Bansal & Bansal, 2003). A 2013 study asked parents of children who had 
been prescribed an EAI whether they were fearful of using it and, if so, what factors that 
may contribute to that fear. Over half of the 1209 parents surveyed expressed fear regarding 
the use of the EAI, which they attributed to hurting the child, using the EAI incorrectly, or a 
negative outcome. Parents whose child had been diagnosed with anaphylactic food allergies 
longer or had experienced a severe reaction in the past and parents who were satisfied with 
the EAI training were less likely to be afraid (Chad et al., 2013). Studies exploring the impact 
of food allergies on families’ quality of life and parental stress have found significant links 
between increased levels of parental distress and worry and family tension compared with 
normative families (Sicherer, Noone & Munoz- Furlong, 2000; King, Knibb & Hourihane, 
2008). A 2008 study with a primary aim of investigating the impact of peanut allergies on 
quality of life and anxiety for children and their immediate family members showed 
significant findings when comparing children with food allergies and their unaffected siblings. 
Children with peanut allergies reported greater separation anxiety than their siblings, likely 
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from a fear of having to manage an anaphylactic reaction to a food by themselves with no 
family help (King, Knibb & Hourihane, 2008). Having to carry medication, or a “shot kit” at all 
times, and the isolation associated with not being able to eat school lunches at the same 
table as their peers further contributes to these children feeling stigmatized and different 
(King, Knibb & Hourihane, 2008). 
In addition to being able to respond effectively to the life threatening aspect of CAH, 
parents must also handle day-to-day condition management. If a child is prescribed too 
much hydrocortisone, side effects can include growth suppression, obesity, and other 
cushingoid features. If the dose of hydrocortisone is not sufficient, children with CAH are at 
a high risk for precocious puberty, which can also lead to stunted growth and adrenal crisis. 
Daily management typically includes replacing deficient levels of cortisol and/or aldosterone, 
while attempting to: minimize androgen excess, prevent virilization, optimize linear growth 
(which is often compromised) and protect future fertility (Merke & Bornstein, 2005). 
Determining the proper dosage of steroids is typically achieved by obtaining routine 
laboratory work and measuring the height, weight and bone age, typically every 3-6 months, 
in a growing child (Merke & Bornstein, 2005). 
Parents of girls born with CAH face additional challenges, as girls born with CAH 
have a significant risk of experiencing virilization, resulting in ambiguous genitalia at birth, 
due to elevated testosterone levels (Witchel & Azziz, 2011). This has the potential to 
profoundly affect both the child and family, as gender assignment of the infant can initially 
be uncertain. Reconstructive feminizing genitoplasty is often recommended at an early age 
and can involve multiple surgeries into adolescence (Witchel & Azziz, 2011). Although the 
majority of girls with CAH have a female gender identity (Dessens, Slijper, & Drop, 2005), 
they often show increased preference for male toys and activities (Pasterski et al, 2005), 
increased aggression (Pasterski et al., 2007), increased male-typical sexual orientation 
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(Nordenstrom et al., 2010), and differences when compared to non-CAH girls in spatial 
abilities (Berenbaum et al., 2012).  
Aims 
The aims for this study include: 
AIM 1. Describe circumstances surrounding adrenal crises in children with CAH by  
examining: 
1.1) Parents’ actual experiences (e.g., what they did, how they used  
information) 
1.2)  Parental perceptions of sources of information related to managing 
time of crisis (e.g., education from healthcare professionals, support 
groups, Internet, etc.); 
1.3)  How such information was delivered (written guidelines, 
demonstration, etc.); 
1.4)  Strategies and approaches parents take to inform other family 
members (siblings, grandparents, etc.), schools, and others in their 
social network (friends, babysitters, etc.) about the management of 
adrenal crises and their perceptions of effective versus ineffective 
strategies to manage them. 
AIM 2.  Explore parents’ perceptions of the consequences, for themselves and their  
family, of living with the possibility that their child with CAH will experience a 
life-threatening adrenal crisis 
AIM 3. Examine a possible relationship between parents’ management ability and  
the impact CAH has on the family (Table 1) 
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Theoretical Framework 
There are many reasons to use a theoretical model as a guide when conducting 
family research. The interface between theory and research has been described as a mutual 
relationship in which research supports theory and theory brings about research questions 
(Young et al. 2001). Theories provide a clear focus for research, including interventional 
work; help in the organization of large amounts of information; and provides a systematic 
way of understanding events, behaviors and/or situations. This study was guided by the 
Family Management Style Framework (FMSF), which is grounded in the originators’ 
research and syntheses of studies of family life in the context of childhood chronic 
conditions (Knafl, Deatrick, & Havill, 2012). (Figure 1) It has been used in studies with 
families exploring the overall response to the child’s condition as well as studies of selected 
aspects of their response (e.g., information management) (Knafl et al., 2012).  
The framework is comprised of three components (with 8 dimensions total): definition 
of the situation (child identity, illness view, management mindset, parental mutuality), 
management behaviors (parenting philosophy, management approach), and perceived 
consequences (family focus, future expectations) (Knafl, Deatrick, & Havill, 2012; Knafl et 
al., 2013). According to the latest revision of the FMSF, individuals in the family contribute to 
developing a family management style or pattern of response that can influence both 
individual and family outcomes (Knafl, Deatrick, & Havill, 2012; Knafl et al., 2013). The 
FMSF has been used widely in family nursing research to date. Some examples of its use 
include studies investigating families of children with brain tumors (Deatrick et al., 2006); 
families of children with cancer (Nelson et al., 2006; Thibodeaux & Deatrick, 2007); families 
with children in the NICU (Bernaix, 2006); and families with genetic conditions (Van Riper, 
2007). 
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Prepared Manuscripts 
This is a three-manuscript dissertation.  Chapter 1 is an introduction to the 
challenges associated with family management of congenital adrenal hyperplasia with 
particular attention to crisis management. Chapter 2 is a systematic review, with an initial 
intent of focusing on family management of CAH; however, results of a preliminary scoping 
study conducted to examine the extent, nature, and range of research related to this focus 
indicated that few, if any, studies had addressed family response (Arksey & O’Malley, 2005; 
Levac, Coloquhoun & O’Brien, 2010). Hence, the aims of the review were expanded 
to focus on the management and care related to children with CAH in order to better 
understand the full extent of chronic condition related management challenges children with 
CAH and their families may face.  
Chapters 3 and 4 are two manuscripts that comprise the dissertation project. Chapter 
3 presents the results of a two-phase, mixed methods study. In Phase 1, parents were 
asked to complete online questionnaires about selected aspects of experiences of family life 
in the context of having a child with CAH. Results from the Phase 1 survey were used to 
select a purposive sample of parents for follow-up interviews. In Phase 2, descriptive, 
qualitative interviews were conducted to elicit more detailed descriptions of parents’ 
experiences of managing CAH-related crises and their perceptions of how the 
consequences of living with the threat of crisis influences their child’s and their family’s life.  
Chapter 4 compares the experiences of parents of girls versus boys with CAH. 
Parents of girls born with CAH often feel the need to keep their child’s diagnosis of CAH 
more private due to their daughters’ ambiguous genitalia, which can create a feeling of 
stigmatization and bring additional challenges to a condition that is already complex to 
manage for both genders. 
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Chapter 5 is a discussion regarding the synthesis of the results of the study, the 
implications of the study, and directions for future research studies to continue this program 
of research. The titles of the chapters are as follows: 
 Chapter 2: Management of Congenital Adrenal Hyperplasia-A Systematic  
Review of the Literature 
Chapter 3: Parental Management of Adrenal Crisis in Children with Congenital 
Adrenal Hyperplasia 
Chapter 4: Gender Matters in Families Having a Child with Congenital Adrenal 
Hyperplasia 
Chapter 5: Discussion 
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Figure 1.1. Family Management Style Framework 
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Table 1.1. Outline of Study Aims and FMSF 
 
Aim of the Study Component of 
Framework 
Topic(s) of Interest Data Collection 
Method 
Describe circumstances 
surrounding adrenal crises in 
children with CAH by examining: 
1.1) Parents’ actual experiences 
(e.g., what they did, how they 
used information) 
1.2) Parental perceptions of 
sources of information related to 
managing time of crisis (e.g., 
education from healthcare 
professionals, support groups, 
internet, etc.); 
1.3) How such information was 
delivered (written guidelines, 
demonstration, etc.); 
1.4) Strategies and approaches 
parents take to inform other family 
members (siblings, grandparents, 
etc.), schools, and others in their 
social network (friends, 
babysitters, etc.) on how to 
manage adrenal crises and 
determine which strategies 
parents perceive to be effective 
versus ineffective.  
Definition of 
the Situation, 
Management 
Behaviors 
Parental perceptions and 
interpretations of adrenal crisis 
events and their beliefs about 
their ability to manage the 
event 
 
Parents’ assessment of the 
extent to which they have an 
established approach for 
responding to an adrenal crisis 
and their strategies for 
accessing and conveying 
information about crisis 
management 
Semi-structured 
Interview; Family 
Management 
Measure – View of 
Condition Impact 
and Management 
Ability Scales; 
PedsQL-Family 
Impact Module 
Explore parents’ perceptions of 
the consequences, for themselves 
and their family, of living with the 
possibility that their child with 
CAH will experience a life-
threatening adrenal crisis 
 
Perceived 
Consequences  
Parents’ perceptions of the 
ways in which the life 
threatening nature of the 
condition affects everyday life 
for their child and family  
Semi-structured 
Interview; Family 
Management 
Measure – View of 
Condition Impact 
and Management 
Ability Scales; 
PedsQL-Family 
Impact Module 
Examine a possible relationship 
between parents’ management 
ability and the impact CAH has on 
the family  
 
Definition of 
the Situation, 
Management 
Behaviors 
The relationship between 
parents’ management ability 
and the impact CAH has on 
the family (e.g. does increased 
ability to manage CAH lead to 
decreased impact of the 
condition on the family?) 
Family 
Management 
Measure – View of 
Condition Impact 
and Management 
Ability Scales; 
PedsQL-Family 
Impact Module 
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 MANAGEMENT OF CONGENITAL ADRENAL HYPERPLASIA-A 
SYSTEMATIC REVIEW OF THE LITERATURE 
Introduction 
Childhood chronic illness can be defined as lasting, or expected to last, more than 
three months and likely producing one or more of the following conditions: a limitation in 
function and/or activity level; a dependency on specific medications, diets, medical 
technology or personal assistance; and/or a need for medical care beyond what is usual for 
a child of the same age (Perrin et al., 1993; Stein et al., 1993; Newacheck & Halfon, 1998). 
Families having a child with a chronic illness face many challenges related to the child’s 
condition such as parental conflict, strained parent-child bond, and sibling-child relationship 
difficulties, which puts them at risk for poor family functioning (Hall et al., 2011; Barlow & 
Ellard, 2006; Cabizuca, Marques-Portella, Mendlowicz, & Coutinho, 2009; Popp et al., 2014; 
van Oers et al., 2014). Families’ having a chronically ill child whose condition is also life 
threatening face the same challenges and often more problematic ones. The need for 
constant vigilance, especially with younger children who do not yet have the ability to 
recognize and respond to crisis events (e.g., hypoglycemic episodes in diabetic children and 
adrenal crisis events in children who are adrenal insufficient), is ever present (Grey et al., 
2011). Families who struggle to cope with the life threatening aspect of their child’s chronic 
condition often have children who report lower quality of life and parents with increased 
psychological distress (Whittemore, Urban, Tamborlane, & Grey, 2003; Streisand, 
Wickmark, Chen, & Holmes, 2005).  
One such episodically life threatening condition is classic congenital adrenal 
hyperplasia (CAH), a rare, genetic, endocrine disorder that requires caregivers to inject 
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hydrocortisone intramuscularly (IM) during times of illness and adrenal crisis (Merke & 
Bornstein, 2005). Management requires parents to not only inject IM hydrocortisone when a 
child is unable to tolerate oral medications and/or if signs of adrenal crisis are present, but to 
also administer oral steroids up to three times daily, supplementing maintenance doses with 
oral “stress dosing” during times of illness (Merke & Bornstein, 2005; Speiser et al., 2010; 
Witchel & Azziz, 2011). The need for stress dosing, either orally or by injection, related to 
simple viral and bacterial childhood illnesses is frequent and unpredictable, often requiring 
parents to make life or death complex treatment decisions (Merke & Bornstein, 2005).  
Moreover, girls born with CAH often experience virilization, which can result in 
ambiguous genitalia at birth due to elevated testosterone levels related to adrenal 
dysfunction (Witchel & Azziz, 2011). This means some families having a child with CAH face 
multiple surgeries into adolescence should reconstructive feminizing genitoplasty be 
recommended (Witchel & Azziz, 2011). These features of the disease have the potential to 
profoundly affect the family, as adrenal crisis events can be fatal, and gender ambiguity 
brings both physical and emotional challenges.  
There are multiple challenges for practitioners and families regarding the treatment 
and monitoring of children with CAH including achieving optimal glucocorticoid replacement, 
height and weight difficulties, excess androgen exposure leading to ambiguous genitalia in 
females, and the need for stress dosing during times of illness and when signs and 
symptoms of adrenal crisis are present (Kim, Ryabets-Lienhard & Geffner, 2012; Merke & 
Bernstein, 2005; Schaeffer et al., 2010; Speiser et al., 2010). In addition to these 
physiological concerns, children and families with CAH must also manage the psychosocial 
aspects of chronic illness, such as dealing with school personnel who are often unfamiliar 
with the condition, the challenges associated with future family planning due to the 
autosomal recessive nature of the condition, decisions related to reconstructive surgery for 
girls with ambiguous genitalia, and the possible stigma associated with the consequences of 
	
	
 16 
excess androgens (Schaeffer et al., 2010; Speiser et al., 2010). The primary purpose of this 
systematic review was to explore the management and care, including treatment modalities, 
associated health issues, and growth and developmental consequences, for children with 
CAH. Examination of family life in the context of CAH is needed to better understand the 
scope of chronic condition-related management challenges these families face. The review 
is intended to provide an evidence base for the development testing of interventions that will 
support optimal family management of CAH.  
Methods 
 Four web-based literature indexes were searched for peer reviewed journal articles 
published from January 2000 to June 2015. It was decided to go back fifteen years to obtain 
a sufficient number of articles, as this is the first review exploring multiple aspects of care 
management related to children with CAH and their families and a comprehensive review 
was needed. Databases searched included PubMed, CINAHL, PsycINFO, and Family and 
Society Studies Worldwide. After consultation with a university health science librarian, the 
following search terms were used: congenital adrenal hyperplasia and family (or parents or 
siblings) as well as adrenal crisis and parents. The words family, parents, and siblings were 
truncated for maximum results.  
 To be included in this review, the studies needed to: 1.) concern CAH management, 
experience, and challenges for children under 18 years, 2.) be written in the English 
language and published between 1/1/2000 and 6/1/2015, and 3.) be peer reviewed. 
Exclusion criteria included: 1.) a primary pathological focus with little detail regarding 
management of the condition, 2.) other adrenal disorders or other disorders that may result 
in ambiguous genitalia, and 3.) articles that focused on non-classical or rare types of CAH. 
This search resulted in 470 articles (Figure 2). After further review of the article titles, 389 
were then excluded, leaving 81 articles from the initial search.  Additional review of the 
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abstracts and full text excluded 55 articles leaving 26. Thirteen other manuscripts that met 
the criteria were added based on review of the reference lists of relevant research articles, 
resulting in a total of 39 empirical reports meeting the search criteria. A defined template 
was used that included information obtained from each report (author/title, research 
purpose, location of study, participant information, data collection methods, and findings). 
Data analysis was completed using a systematic approach consisting of sorting, 
categorizing, and summarizing data in an effort to create meaningful conclusions 
(Whittemore & Knafl, 2005). 
Results 
 Thirty-nine empirical research studies met the criteria and were included in this 
review. Thirty-four studies used a quantitative design, four used a mixed methods design, 
and one study used a qualitative design. These studies had global representation with North 
America, South America, Europe, Australia and Asia all having reported research on 
children with CAH. Of the 39, fifteen were conducted in the United States (U.S.), thirteen in 
Europe (with the majority of European studies coming from the United Kingdom (U.K.)), 
eight in Asia (Jordan, Turkey, India, and Malaysia), three from Brazil, and one from 
Australia. One study was conducted jointly in the U.K. and the U.S. In the United States, 
studies were primarily conducted in Bethesda, Maryland (at the National Institutes of 
Health), in Los Angeles, New York, and in states described by the authors as in the “mid-
western region.”  
Four themes emerged from the 39 studies: 1.) health and development issues 
associated with a diagnosis of CAH (n=10); 2.) physical and psychosocial consequences for 
the child resulting from exposure to excess androgens (n=18); 3.) the life experience of 
having CAH for those affected and their families (n=7); and 4.) acute illness and managing 
and averting adrenal crisis (n=4). 
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Health and Development Issues Associated with CAH  
 Children with CAH are steroid dependent for life, and the goal of daily maintenance 
treatment is to replace deficient levels of cortisol and/or aldosterone while minimizing 
androgen excess, preventing virilization, optimizing linear growth, and protecting future 
fertility. If children are prescribed excess hydrocortisone, side effects can include growth 
suppression, obesity, and other cushingoid features. If the dose of hydrocortisone is not 
sufficient, these children are at a high risk for precocious puberty, which can also lead to 
stunted growth and adrenal crisis (Merke & Bornstein, 2005).  
Ten studies focused on aspects of CAH that lead or have the potential to lead to 
negative health outcomes (Table 2.1). Of the ten, five articles focused on growth issues, 
both height and weight, in these children. Obesity was found to be a significant problem in 
children with CAH (Volkl, Simm, Beier, & Dorr, 2006; Mendes-dos-Santos et. al, 2011; 
Cetinkaya & Kara, 2011; Moreira et al., 2013). Medes-dos-Santos et al. (2011) concluded in 
their cross sectional, retrospective study that height in these children was similar to 
unaffected children of the same age, yet children with CAH had higher body fat, which 
tended to be visceral. Volkl et al. (2006), in a cross-sectional study, examined Bavarian 
children with CAH and found that steroid dosing, age, advanced bone age maturation, and 
parental obesity all contributed to elevated body mass indexes (BMI); while birth height and 
weight, the types of glucocorticoids prescribed, and mineralocorticoid use were not 
associated with obesity. Similarly, Moreira et al. (2013) found that CAH children presented 
with a higher prevalence of obesity and metabolic syndrome, and like Volkl et al., child 
weight did not seem to be correlated with glucocorticoid treatment. Cetinkaya and Kara 
evaluated the effects of glucocorticoid doses on bone mineral density in their 2011 study 
and found that children with CAH have higher BMIs than healthy controls. The bone ages of 
the poorly controlled (when looking at 17 hydroxyprogesterone (17-OHP) levels) and late-
diagnosed groups were higher than tightly controlled, early-diagnosed groups. Additionally, 
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treatment of glucocorticoids did not appear to influence bone mineral density in CAH 
children.  
Using a descriptive design, Bonfig, Schmidt, and Schwartz analyzed linear growth 
patterns in children with CAH treated with low doses of hydrocortisone during their first three 
years of life (2011). In their cohort of fifty-one children, birth length was above average in 
boys and girls, possibly due to increased androgens in utero, which correlated with Bonfig’s 
2007 study results as well. Treating these children with lower levels of glucocorticoids in 
infancy did not accelerate bone age and growth, and they were able to achieve height within 
the target range as they grew. However, final height in these children was still decreased 
(Bonfig et al., 2007). Lin-Su, Harbison, Lekarev, Vogiatzi, and New (2011) evaluated 
whether growth hormone (GH) alone or in combination with a leutinizing hormone releasing 
hormone agonist (LHRHa) would improve final height in children with CAH, as LHRHa can 
effectively suppress puberty, preserving the ability for continued growth. These findings 
indicate that for CAH children experiencing precocious puberty and short stature, GH alone 
or in combination with LHRHa is an effective therapy for improving final height; however, 
males experience somewhat less height benefit than females.  
Due to a variety of factors, children with CAH are at risk for vascular problems 
(Harrington, Pena, Gent, Hirte, & Couper, 2012); hence a study was designed to establish 
whether children with CAH have reduced vascular function and increased carotid intima 
media thickness (cIMT) when compared to healthy children. The findings of this cross-
sectional study suggest that CAH children have significant vascular and smooth muscle 
dysfunction when compared to healthy controls, and this level of dysfunction was 
comparable to the healthy subjects that were mild to moderately obese. Risk factors that 
were identified with the potential to cause such vascular dysfunction in these children 
include obesity, insulin resistance, hypertension, dyslipidemia, hypercortiosolism, and 
hyperandrogenism (Harrington et al., 2012). The authors conclude that these children are at 
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risk for cardiovascular problems later in life and education related to healthy lifestyle choices 
such as exercise and proper nutrition for these families is needed to diminish possible 
negative health outcomes as these children age (Harrington et al., 2012). 
A 2006 retrospective, descriptive study was conducted to determine the incidence of 
urinary tract infections (UTIs) in children with CAH (Nabhan, Rink, & Eugster). Since girls 
with CAH often experience ambiguous genitalia that may result in structural genitourinary 
anomalies, the authors hypothesized these girls may be at higher risk for such infections. 
Both boys and girls with CAH were included in the study. The incidence of UTIs in children 
with CAH was similar to the general population; furthermore, there was not a significant 
increase in UTIs if genital surgery was delayed in affected girls. 
Finally, one study investigated the behavioral health of children with CAH. Idris et al. 
(2014) studied behavioral outcomes in children with CAH compared to a non-affected, 
control group. They found a higher incidence of parent reported child problems including 
anxiety, depression, somatic complaints, social and attention problems, and aggressive 
behavior when compared to controls. Internalizing behavior problems were seen more often 
in boys with CAH compared with control boys, and CAH girls had similar psychosocial 
adjustment to their non-affected girl control counterparts. Idris et al. further found a 
relationship between increased parent reported child problem behavior and higher 
glucocorticoid doses and/or lower family income (2014).  
Physical and Psychosocial Consequences from Exposure to Excess Androgens 
 Both female and male children born with CAH are exposed to high concentrations of 
androgens in utero; while males do not show any outward physical signs of this exposure 
(except possibly subtle hyperpigmentation and penile enlargement), females typically have 
ambiguous genitalia at birth to varying degrees, which often leads to a diagnosis in females 
shortly after delivery. The degree of virilization is graded according to the Prader score (with 
a 0 appearing as a typical female and a 5 appearing as a typical male). Gender assignment 
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in these affected females can pose both a medical and family crisis (Merke & Bornstein, 
2005). The majority of the studies reviewed (18) addressed the potential impact of excess 
androgen exposure on the physical genitalia characteristics and psychosocial presentations 
of children with CAH. (Table 2.2)  
The aim of a 2004 retrospective study in Turkey was to report on the experience of 
gender (re) assignment in genotypical female patients with CAH. Seventy female patients 
were studied with 21 of them having been reared “male.” Nine of them were surgically 
reassigned as females, with a mean age of seven months at the time of surgery. The study 
found significant difficulties, both in surgical complications as well as family emotional strain, 
in attempting to correct the gender of female patients with CAH when they present at greater 
than 2.5 years of age (Ozbey, Darendeliler, Kayserili, Korkmazlar & Salman, 2004).  
Another study (Al-Maghribi, 2007), based in Jordan, evaluated the clinical features of 
all patients with CAH treated at a major medical center from 1996-2006. Among the 39 
females born with CAH, 27 had problems with external genitalia. Seven of these chose not 
to have reconstruction surgery and six of these had hysterectomies and gonadectomies to 
keep their “male genders.” Although the majority of these female children did have 
reconstructive surgery and were raised as girls, fifteen percent were genetically identified as 
female, but physically reconstructed, and raised as male. There were no other studies found 
that described these types of surgical measures to preserve male identity, which could be 
based on cultural differences related to gender roles in middle eastern countries. In addition, 
in areas where there are universal newborn screenings such as in the U.S. and most of 
Europe, incorrect gender assignment after the first few weeks is uncommon (Servin, 
Nordenstrom, Larsson & Bohlin, 2003). Although there is controversy regarding early 
reconstructive surgery for females with regards to eventual sexual satisfaction, it remains 
the recommendation by most pediatric endocrinologists in Europe and the U.S. (Schaeffer et 
al., 2010; Merke & Bernstein, 2005; Ozbey et al, 2004).  
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A 2002 study in Germany (Woelfle et al.) examined sixteen completely virilized 
females in an effort to better understand specific problems these girls face. In this study, 
gender identity was defined as “an individual’s internalized sense of males or femaleness 
and the acceptance of the gender role of that sex as appropriate” (Woelfle et al., 2002, p. 
233). The authors of this study define the circumstance of a female born with ambiguous 
genitalia due to CAH as “female pseudohermaphroditism,” which is a term that would likely 
not be accepted or welcomed in the general CAH population, nor medical communities that 
treat CAH globally (Matos, 2015). The authors concluded that there are five main concerns 
experienced in this population: 1.) delayed diagnosis (due to an assumption of the child 
being a male rather than female), 2.) gender assignment, 3.) surgical procedures, 4.) short 
stature, and 5.) precocious puberty. All of these issues, with the exception of gender 
assignment and related subsequent surgical procedures, also affect males with CAH. 
Similarly, a 2010 study in India used a case study approach to report the effect of steroid 
therapy during infancy and early childhood on the appearance of the external genitalia of 
girls with CAH (Kulshreshtha et al., 2010). It is unclear as to whether the three girls in the 
study had a definitive diagnosis of CAH, as steroids were not initiated until after two months 
of age in one and as late as 2.5 years in another. However, the authors concluded that there 
is improvement in the external appearance of the girls’ genitalia with post-natal steroid 
therapy. 
 Four cross-sectional studies examined toy preferences in children with CAH from the 
first year of life to young adulthood. In both the Servin et al. and Wong et al. (2003, 2013) 
studies, girls with CAH were more interested in masculine toys such as cars and 
construction toys versus feminine toys such as dolls and tea sets. In the Wong study, which 
also looked at parental encouragement of sex-typical toy play, parents of girls in both CAH 
and control groups encouraged girl-typical toy play; however, parents reported encouraging 
less girl-typical, and more boy-typical, toy play in girls with CAH than in control females. The 
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authors suggest that this could be due to the fact that parents simply encourage their 
children to play with toys that the child naturally prefers. Servin et al. (2003) examined the 
degree of masculinization for girls with CAH in regards to play behavior and attempted to 
identify playmates by asking the girls whom their “best friends” were. Two thirds of girls with 
severe masculinization reported a boy as their best friend, where most of the girls with 
milder forms of CAH and all of the control girls reported girls as their best friend. In addition, 
the group of girls with CAH who had the most masculinization spent significantly more time 
playing with masculine toys than girls with less masculinization. 
A 2005 study by Pasterski investigated 65 CAH children, both male and female, as 
well as controls, to assess toy choices. As in the Servin and Wong studies, Pasterski et al. 
found that girls with CAH, aged 3-10, displayed more male-typical toy choices than controls, 
whereas boys with and without CAH did not differ. Similarly, a 2002 study (Nordenstrom et 
al.) not only investigated toy preference in girls with CAH, but also explored a relationship 
between the degree of disease severity, reflected in CYP21 genotype, and the degree of 
masculinization with toy play and preference. They too found that girls with CAH played 
more frequently with masculine type toys than controls; additionally, the higher degree of 
androgen exposure in utero did correlate with an increased preference of masculine toys.  
A 2004 study explored if school aged girls with CAH had problems with gender 
identity due to increased androgen exposure prenatally and hypothesized that if the gender 
identity of CAH females was determined by prenatal androgens, one would expect 
indications of increased gender confusion or gender dysphoria to be evident in childhood 
(Meyer-Bahlburg et al., 2004). As expected based on previous studies, girls with CAH 
scored significantly more masculine than control girls on all scales used when looking at 
gender behavior; however, there was an absence of gender confusion/dysphoria. This 
varies slightly from Berenbaum and Bailey’s 2003 study that showed that the vast majority of 
girls with CAH had similar scores (on a nine-question interview) to those of control girls, but 
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the average score was in between control girls and “tomboys,” which is not defined. 
However, girls with CAH, as also reflected in Meyer-Bahlburg’s study, did not express true 
gender confusion and articulated no discomfort in being a girl. Beltz, Swanson, and 
Berenbaum (2011) explored the contribution of androgens on occupational interests in 
males and females with CAH compared to their same gender, unaffected siblings in an effort 
to better comprehend women’s lack of representation in careers focused on science and 
technology. The framework used was “Things versus People,” which stipulates that males 
prefer occupations related to objects and females prefer occupations related to people. 
Females with CAH did have more interest in “things” over “people” when compared to 
unaffected females and variations among females were significant to the degree of 
androgen exposure in utero (Beltz, Swanson, and Berenbaum, 2011). 
 Pasterski et al. (2015) studied 153 children total (43 females and 38 males with CAH 
as well as unaffected relative controls) to investigate potential cross gender identification in 
girls who were exposed to androgens prenatally. This was one of four studies evaluating the 
physical and psychosocial consequences of exposure to excess androgens that used a 
mixed methods approach in which standardized measures as well as a short parent and 
child interview were conducted. In this study, gender role behavior “refers to behaviors 
which, on average, are more typical of one gender or the other and includes preferences for 
specific toys, playmates and play styles” while gender identity was defined as “the sense of 
self as male, female, or a category that is neither male nor female” (Pasterski et al., 2015, 
p.1364). The study found that girls exposed to high levels of androgens in utero due to CAH 
show increased cross gender identification as well as cross gender role behavior, when 
compared to female controls (Pasterski et al., 2015).  
 Spatial ability is typically described as the ability to understand and remember the 
spatial relations among objects. The largest cognitive sex difference is in spatial ability, with 
males outperforming females in most aspects (Berenbaum, Bryk, & Beltz, 2012). Spatial 
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abilities in males with CAH show inconclusive results. A 2003 study showed that males with 
CAH have unaltered performance on targeting tasks and impaired performance on internal 
rotation tasks compared to unaffected males, yet a 2012 study showed males with CAH 
scoring lower than their unaffected brothers in spatial ability (Hines et al., 2003; Berenbaum 
et. al., 2012). For females however, both studies suggest that females with CAH perform 
better than unaffected females on spatial ability measures and resemble unaffected males 
and males with CAH in this respect (Hines et al., 2003; Berenbaum et. al., 2012).  
Knickmeyer et al. (2006) investigated whether autistic traits among boys and girls 
with CAH are increased as a result of exposure to excess androgens. The Autism Spectrum 
Questionnaire (AQ) was given, and females with CAH scored significantly higher than 
unaffected females, in large part due to increased scores on subscales measuring social 
skills and imagination. However, none of the females in the study had AQ scores that met 
the cut off for suspicion of a clinical diagnosis of autism among the general population. 
Males with CAH did not differ from unaffected males on the total AQ or on any of its 
subscales.  
 Finally, four studies evaluated possible personality differences in children with CAH 
due to excess androgen exposure. Females with CAH tend to display increased aggressive 
behavior and activity levels in childhood (Pasterski et al., 2007; Mathews, Fane, Conway, 
Brook & Hines, 2009). However, such results in males is less conclusive with one study 
reporting no significant differences in either aggressive behavior or activity level (Paterski et. 
al, 2007) while another showed males tend to display less dominant, less rough and tumble 
play and show increased “tender minded” characteristics (Mathews et al., 2009). The 
rationales offered by the authors as to why males with CAH might display less dominant 
behavior than unaffected males is based the possibility of non-hormonal factors, particularly 
illness, associated with CAH or that testosterone levels may be initially elevated, but due to 
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neural feedback mechanisms, may readjust to normal or even lower than normal levels 
(Mathews et al., 2009).  
 Prenatal treatment of dexamethasone (Dex) in pregnant women at risk for having a 
child with CAH was introduced decades ago (Nimkarn & New, 2009) with the understanding 
that taking steroids during pregnancy reduces the risk of virilization in the unborn female 
fetus with CAH by reducing the level of circulating adrenal androgens. Maryniak et al. (2014) 
studied 33 females in Poland ranging from 6-23 years of age from at-risk CAH families; 17 
girls treated prenatally with Dex (9 affected and 8 unaffected after birth) and 16 CAH 
affected females that were not treated prenatally. The purpose of the study was to assess 
cognitive development and social and emotional function in girls treated with 
dexamethasone prenatally compared to female CAH patients who were not treated 
prenatally. The authors found that prenatal treatment with Dex was significantly associated 
with better cognitive functioning (based on measures including an intelligence scale as well 
as memory and verbal learning tests) in girls with CAH; however, treating unaffected CAH 
girls (in utero prior to knowing if they will have CAH or not) can cause the risk of unfavorable 
influence on the development of certain cognitive functions. Hence, prenatal Dex treatment 
in mothers should be discontinued immediately after determination of the unborn child’s 
CAH status and/or gender. As reflected in other studies (Beltz et al., 2014; Maryniak et al., 
2014; Nordenstrom et al., 2002; Pasterski et al., 2005; Servin et al., 2003; Wong et al., 
2013), prenatally untreated CAH girls had more male “interests” than unaffected and CAH 
affected/treated prenatally with Dex girls.  
The Life Experience of Having CAH for Those Affected and Their Families 
 Families having a child with CAH often experience challenges such as missed school 
and work, frequent times of illness, isolation, and a decreased quality of life (Fleming et al, 
2011; Boyse et al., 2011; Yau et al., 2015).  Seven studies, one of which was qualitative, 
focused on the experience of having CAH from the perspective of either the child with CAH, 
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family members, or both (Table 2.3).  Three of the studies focused on parents of children 
with CAH in developing countries: Sri Lanka, Vietnam and India (de Silva et. al., 2014, 
Armstrong, Henderson, Hoan & Warne, 2006; Bhakhri & Jain, 2011). Children’s 
perspectives were not given; however parents in the three countries reported 
misconceptions and confusion with medication administration and general knowledge of the 
disorder. Other similar concerns expressed by parents from these countries included 
surgical options and care for their daughters with CAH as well as the financial burden 
associated with having a chronically ill child. Authors concluded that there is a strong need 
for more support groups in helping parents deal with such struggles as well as more 
universal newborn screenings (Armstrong, Henderson, Hoan & Warne, 2006; Bhakhri & 
Jain, 2011). The de Silva study (2014) examined depressive symptoms in parents of 
children with CAH and found over half of the parents of children with CAH were classified as 
having symptoms of depression that did not subside with the passage of time.  
In the United States, Boyse et al. (2014) conducted a small, qualitative study (6 
parents from 4 families) examining the experience of having CAH for children and their 
families and identified multiple challenges facing families having a child recently diagnosed 
with CAH. These included communication problems with health care providers, especially 
regarding parents’ understanding of the diagnosis and treatment options and the need for 
decision making regarding genital surgery in girls, as well as a lack of social support. These 
challenges left parents feeling overwhelmed and isolated as well as concerned that their 
knowledge of how to manage the condition was insufficient (Boyse et al., 2014). 
Three additional studies examined aspects of families’ quality of life related to their 
child’s CAH diagnosis. Sanches et. al (2012) investigated the physical, social, and societal 
functioning of children with CAH and their parents in The Netherlands through parent report. 
Parents reported that their child with CAH experienced few negative effects from the 
condition, with children participating (as unaffected children would) in typical school and 
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leisure activities, but also noted needed improvements in parental preparation for adrenal 
crisis events in their children. Gilban, Alves and Beserra (2014) evaluated the health related 
quality of life (HRQoL)  of children and adolescents with CAH in Brazil. This was one of the 
few studies that used measures completed by both parents and affected children. They 
found a loss of HRQoL in children and teens with CAH, especially in the physical dimension 
(when compared with unaffected controls), which was in agreement with the assessment 
made by their parents. There were no statistically significant differences in quality of life 
between boys and girls with CAH however. Finally, Yau et al. (2015) evaluated the HRQoL 
in children with CAH, with a specific focus of comparing children with CAH and children with 
other endocrine conditions (hypothyroidism). Hypothyroidism was chosen because it too 
“requires the administration of daily medication and continuous medical assessment 
throughout childhood” (Yau et al., 2015, p.2). Based on both parent and child reports, 
children with CAH had an overall decrease in HRQoL compared to both healthy children and 
children with hypothyroidism in school functioning. Furthermore, CAH children more 
frequently reported peers not wanting to be friends.  
Acute Illness and Managing and Averting Adrenal Crisis 
 Four studies focused on acute illness, stress dosing, and adrenal crisis experiences 
and management in children with CAH (Table 2.4). Three of the four examined the role that 
physical stress, such as exercise and acute illness, had on metabolic processes such as 
glucose regulation in children with CAH. In a randomized, double blind, crossover study 
from 2004, Weise et al. examined whether an extra dose of hydrocortisone would help 
normalize blood glucose levels in patients with CAH during exercise, as children with CAH 
do not mount the normal exercise-induced glucose response due to lack of cortisol 
production with physical activity (Weise et al., 2004; Green-Golan et al., 2007). The authors 
concluded that children with CAH do not benefit from additional hydrocortisone during short-
term exercise, as the extra hydrocortisone did not increase blood glucose levels. Supporting 
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these findings, a 2010 study examined blood glucose levels and physical symptoms during 
typical acute viral or bacterial illnesses at home (Keil, Bosmans, Van Ryzin & Merke). 
Children with CAH who were being “stress dosed” appropriately during common childhood 
illnesses are at risk for hypoglycemia during the illness course. This suggests the need for 
additional glucose supplementation in addition to “stress dosing” during times of acute 
illness (Keil et al., 2010). Finally, a 2011 study assessed 60 caregivers’ knowledge of CAH, 
adrenal crisis, and stress dosing as well as their confidence in responding to adrenal crises 
(Fleming, Rapp & Sloane). The majority of caregivers responded that their child experiences 
a “crisis” situation an average of one to two times per year. Caregivers seemed to have a 
strong, basic understanding of the disorder; moreover, those that received both a written 
instruction guideline and a demonstration by clinicians on how to stress dose, both orally 
and via an injection, scored significantly higher when looking at self-efficacy (Fleming et al., 
2011). 
Discussion 
Studies that met the inclusion criteria for this systematic review were primarily 
conducted using quantitative methods and were cross-sectional and descriptive in nature, 
with the sample population coming from either one institution or one city. Studies that use 
only samples from within one institution typically have the same group of pediatric 
endocrinologists treating children with CAH in a similar manner regarding medication 
dosing, family education, etc., which has the potential to affect the results, especially when 
looking at factors such as growth patterns. Many of the studies used structured measures, 
but did not report on their reliability and validity. Only one out of 39 studies involved an 
intervention (Lin-Su et al., 2011). This study examined the effect of growth hormone on final 
height in children with CAH, but was not a randomized, controlled study. Since most children 
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with CAH do not require growth hormone treatment, its applicability to the general CAH 
population is limited.  
All of the investigators whose research focused on acute illness, stress dosing, and 
adrenal crisis either acknowledged having a small sample size (Keil et al., 2010; Fleming et 
al., 2011) or had a sample size less than 10 (Weise et al., 2004; Green-Golan et al., 2007). 
There were five studies that investigated body weight in children with CAH; however, only 
the Volkl et al. study accounted for parental BMIs and inquired about daily dietary intake for 
these children, making it difficult to know if the child’s weight was directly influenced simply 
by the child having CAH and not environmental or familial factors. 
Two of the studies dealing with the family experience were in developing countries 
where steroids were reported to be expensive based on the typical amount of family income, 
and parents in these studies reported that medication cost was a significant concern 
(Armstrong, Henderson, Hoan & Warne, 2006; Bhakhri & Jain, 2011). This particular 
difficulty is likely not to be as prevalent in more developed countries such as those in Europe 
or in Canada and the U.S.; thus, it is probable that a similar study conducted in these 
countries would yield different results.  
Overall, there is a heavy emphasis placed on gender behavior and identity, yet very 
little research on how families manage the social challenges associated with girls born with 
ambiguous genitalia. With the exception of the Wong et al. and Nordenstrom et al. studies 
(2013, 2002) which involved the use of some observational methods, investigators relied on 
parents’ reports of their child’s play preferences over the course of their development. In 
addition, very few confounding variables (e.g. gender of other siblings) were addressed in 
the majority of studies investigating the effects of androgens on gender-related play and toy 
preferences. For example, a girl with CAH having three older brothers might be living in an 
environment where most toys were boy-typical. In addition, the observers who were 
interpreting the play behavior of the children in the studies and their training were not 
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described. Again, as reflected in previously discussed studies, investigators rarely collected 
data on aspects of family life such as marital status or parenting competence that could 
potentially influence child personality traits such as aggression and activity level. Since 
these studies focused on children, the lack of longitudinal studies, especially with regards to 
child preferences, is significant. The effects of excess prenatal androgens on both males 
and females with CAH have been studied in depth over the last fifteen years; however, there 
are few qualitative or mixed method studies on this issue. Ambiguous genitalia and the 
physical and emotional struggles associated with it are likely sensitive topics for research 
and the related effects might not be adequately represented in questionnaires and surveys 
completed by parents and children with CAH.  
As stated, studies were focused primarily on potential health complications 
associated with CAH, emergency management of the disorder, and potential consequences 
of excess androgen exposure; however, few studies examined the implications of these 
significant problems on families managing their child’s CAH. The lack of knowledge in this 
area limits the conclusions that can be made about family management and experience with 
CAH.  
Future Implications for Practice and Research 
While CAH has similarities to other chronic, life threatening illnesses such as type 1 
diabetes and asthma, which have previously been studied through a family lens, more 
research is needed to identify the ways having a child with CAH intersects with family life. 
For example, when parents are not properly instructed on how to handle the emergency 
aspects of CAH management, the result can be not only improper use of emergency 
medical services (EMS) services and emergency departments in hospitals, but also, and 
more significantly, serious injury and possible death of the child. Understanding and 
identifying gaps in parent education by healthcare professionals, especially concerning 
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times of adrenal crisis, is necessary to promote positive outcomes, both from an emotional 
and physiological family perspective (Fleming, Rapp & Sloane, 2011). In addition, parents of 
girls born with CAH likely feel the need to keep their child’s diagnosis of CAH more private 
due to potential stigmatization, which adds another challenge to a disorder that is already 
complex to manage. Acknowledging this difference and studying the effects of support 
systems designed specifically for girls born with CAH that address both the surgical 
procedures often associated with ambiguous genitalia as well as possible long-term 
complications resulting from being born with elevated testosterone is critical to promoting a 
healthy family response to the disorder. Future studies with an emphasis on family 
experience and management would enhance the current state of the science and provide a 
much-needed window into prospective interventions aimed at improving the lives of families 
and children with CAH. 
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Table 2.1. Summary of Articles: Health Related Issues Associated with CAH Diagnosis 
 
Author (Year) Sample/Setting Purpose Study Design Conclusions 
 
Bonfig et al. 
(2007) 
68 patients with salt-
wasting CAH  in one 
clinic 
To determine final height 
outcome and influences of 
steroid treatment 
Retrospective 
 
Patients with CAH are able to achieve adequate 
final height with conventional therapy. Total 
pubertal growth is significantly decreased and 
treatment with prednisone results in decreased 
final height.  
Bonfig et al. 
(2011) 
51 patients with CAH 
ages birth to 3 years in 
Bavaria. Both genders. 
To analyze growth patterns in 
children with CAH diagnosed 
by newborn screening and 
treated with relatively low 
doses of hydrocortisone during 
the first year of life. 
 
Cross sectional/ 
Descriptive 
Birth length is above average in children with 
classical 
CAH, which might be the result of untreated 
hyperandrogenism in utero. Relatively low doses 
of hydrocortisone treatment in the first 3 years 
results in heights that achieve genetic height 
potential. 
Centinkaya & 
Kara (2011) 
26 children with CAH and 
11 healthy controls ages 
2-15 years in Turkey. 
Both genders. 
 
To evaluate the effects of 
gluocorticoid doses on bone 
mineral density (BMD) in 
children with CAH and to 
investigate other factors 
influencing BMD 
Cross sectional/ 
Descriptive 
Children with CAH have higher BMIs than healthy 
controls. The bone age of the poorly controlled 
group (looking at 17ohp), late diagnosed groups 
and male patients were higher than the tightly- 
controlled group, early diagnosed group and 
female patients. 
Harrington et al. 
(2012) 
14 patients with CAH and 
28 obese and 53 healthy 
controls ages 9-20 in 
Australia. Both genders. 
 
To establish whether children 
with CAH have reduced 
vascular function and 
increased carotid intima media 
thickness (cIMT) when 
compared to healthy and 
obese children. 
Cross sectional/ 
Descriptive 
CAH children have significant vascular endothelial 
and smooth muscle dysfunction when compared 
to healthy controls. The vascular dysfunction was 
comparable to the subjects with mild to moderate 
obesity.  
	
	
 
35 
Author (Year) Sample/Setting Purpose Study Design Conclusions 
 
Idris et al. (2014) 49 patients between the 
ages of 6-18 that attend 
a medical center in 
Malaysia. Both genders. 
To determine the status of the 
behavioral outcome in children 
with CAH compared to a 
control group of children 
without CAH and to identify the 
risk factors that may influence 
it 
Cross sectional/ 
Descriptive 
There was a higher incidence of parent reported 
problems of anxious/depressed and 
withdrawn/depressed behaviors, somatic 
complaints, social, thought, and attention 
problems and rule-breaking, aggressive, 
internalizing and externalizing behavior among 
CAH children compared to controls. Internalizing 
behavior problems were higher in CAH boys 
compared with controls; CAH girls had similar 
psychosocial adjustment to the control group. 
Family income (the lower the income, the more 
behavior problems) and glucocorticoid dose (the 
higher the dose, the more behavior problems) 
were significantly related to parent reported 
problem behavior. 
Lin-Su et al. 
(2011) 
34 patients with CAH 
treated with GH with a 
mean age of 8 yrs in 
New York, USA. Both 
genders. 
 
Examine whether growth 
hormone (GH)  alone or in 
combination with leutinizing 
hormone releasing hormone 
antagonist (LHRHa) improved 
the final adult height in patients 
with CAH 
Non randomized/ 
Prospective with 
an intervention 
GH alone or in combination with LHRHa improves 
final adult height in patients with CAH. 
Medes-dos-
Santos et al. 
(2011) 
21 pre-pubertal patients 
ages 2-10 years old with 
CAH and 67 healthy 
controls in Brazil. Both 
genders.  
To evaluate growth and body 
composition of patients with 
CAH and to compare them 
with healthy children 
Cross sectional/ 
Retrospective/De
scriptive  
Patients had growth recovery with mean height 
similar to the general population; however, they 
had higher body fat, which seemed to be visceral, 
since there was not difference between the 
skinfolds of both groups. 
Moreira et al. 
(2013) 
33 patients ages 6-17 
who attend a clinic in 
Sao Paulo, Brazil. Both 
genders. 
To investigate the prevalence 
of obesity and metabolic 
syndrome in young patients 
with CAH and to correlated this 
prevalence with glucocorticoid 
treatment and family history 
Cross sectional/ 
Comparative 
CAH patients presented a higher prevalence of 
obesity and metabolic syndrome, which were not 
correlated with the glucocorticoid treatment 
suggesting that obesity and familial predisposition 
are significant determining factors for an adverse 
metabolic profile in CAH patients. 
Nabhan et al. 
(2006) 
71 patients with CAH 
ages 15 and younger in 
Indianapolis, USA. Both 
genders. 
Investigate the incidence of 
urinary tract infections (UTIs) 
in children with CAH and to 
determine whether there was a 
correlation between timing and 
type of genital surgery in girls 
 
Cross sectional/ 
Descriptive/Retro
spective 
The incidence of UTIs in children with CAH is 
similar to the general population. There is not a 
suggested increase in UTIs if genital surgery in 
girls is delayed. 
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Author (Year) Sample/Setting Purpose Study Design Conclusions 
 
Volkl et al. (2006) 89 children and 
adolescents with ages 
birth through 17 in 
Bavaria. Both genders. 
 
Analyze BMI values, compared 
with population-based 
references, for children and 
adolescents with CAH 
 
Cross sectional/ 
Retrospective 
Children and adolescents with CAH have a higher 
risk of obesity. Glucocorticoid dosage, chronologic 
age, advanced bone age maturation, and parental 
obesity contributed to elevated BMI SDS, whereas 
birth weight and length, serum leptin levels, used 
glucocorticoid, and mineralocorticoid dosage were 
not associated with obesity.  
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Table 2.2. Summary of Articles: Physical and Psychosocial Consequences from Exposure to Excess Androgens 
 
Author 
(Year) 
Sample/Setting Purpose Study Design Conclusions 
Al-Maghribi 
(2007) 
The records of 73 
children (39 were 
genetic females and 
34 were genetic 
males) with CAH ages 
five months to 18 
years in Jordan. Both 
genders  
To evaluate the clinical 
features of all of the patients 
with CAH who were followed 
at the King Hussein Medical 
Center in Jordan from 1996-
2006. 
Descriptive/ 
Retrospective 
Among the 39 females with CAH, 27 had developed 
anomalies of the external genitalia; 20 of them underwent 
surgical interventions of their external genitalia. Fourteen 
genetically female patients were wrongly diagnosed as 
'male sex' at birth due to severe virilization. Seven of them 
were reassigned 'female sex' socially, legally, and 
surgically; the parents of one of them (a four-year-old girl) 
wanted the surgical intervention postponed for two to 
three years. Hysterectomy and gonadectomy were carried 
out for 6 of the other 7 patients who chose to keep the 
male genders.  
Beltz et al. 
(2011) 
125 individuals: 46 
females with CAH; 21 
without and 27 males 
with CAH; 31 without 
ages 9-26 years in 
Mid-western USA. 
Both genders. 
To explore the contribution 
of sex hormones on 
occupational interests in 
females and males with 
CAH compared to their 
same gender, unaffected 
siblings. 
Cross sectional/ 
Descriptive 
Females with CAH had more interest in “things” versus 
“people” than unaffected females and variations among 
females were congruent with degree of exposure to 
androgens. 
Berenbaum 
& Bailey 
(2003) 
43 girls with CAH, 7 
tomboys, and 29 
sister/cousin controls 
ages 3-18 years in 
USA. All girls. 
To study gender identity in 
girls with CAH in relation to 
characteristics of the 
disease and treatment, 
particularly genital 
appearance and surgery 
Mixed Methods/ 
Descriptive 
Gender identity in girls with CAH was not related to 
degree of genital virilization or age at which genital 
reconstructive surgery was done. 
 
Berenbaum 
et al. 
(2012) 
58 males and females 
with CAH and 27 
unaffected siblings 
ages 16-30 in mid-
western USA. Both 
genders. 
To study effects of early 
androgens on spatial and 
mechanical abilities in 
adolescents and young 
adults with CAH 
 
Cross sectional/ 
Descriptive 
Increased spatial ability was enhanced for females with 
CAH compared to their unaffected sisters. Males with 
CAH showed reduced spatial abilities compared to their 
unaffected brothers.   
Hines et al. 
(2003) 
128 participants: 40 
females and 29 males 
with CAH and 29 
unaffected female and 
30 unaffected male 
relatives of individuals 
with CAH ages 12-45 
years in London. Both 
genders 
To investigate the androgen 
influences on spatial abilities 
Cross sectional/ 
Descriptive 
Females with CAH performed better than unaffected 
females on spatial ability tests and resembled unaffected 
males and males with CAH. Males with CAH showed 
unaltered performance on the targeting tasks, and 
impaired performance on the mental rotations tasks.  
	
	
 
38 
Author 
(Year) 
Sample/Setting Purpose Study Design Conclusions 
Knickmeyer 
et al. 
(2006) 
60 individuals with 
CAH (34 females, 26 
males), and 49 
unaffected relatives 
age 12-45 years in 
London. Both genders. 
To examine the hypothesis 
that autistic traits are 
increased following prenatal 
exposure to abnormally high 
levels of testosterone 
caused by CAH 
Cross sectional/ 
Descriptive 
Females with CAH scored significantly higher than 
unaffected females on the total Autism Spectrum Quotient 
questionnaire, largely due to enhanced scores on 
subscales measuring social skills and imagination.  
 
Kulshreshth
a et al. 
(2010) 
3 individuals with CAH 
age 2 to 4 years that 
attend a clinic in India. 
Females 
To report on the effect of 
steroid therapy during 
infancy and early childhood 
on the appearance of the 
external genitalia of girls 
with CAH. 
Longitudinal/ 
Case Study 
Unclear if patients in the study suffered from classical 
CAH, although that is the determination of the authors, 
despite none of the 3 children beginning steroid treatment 
until after the age of 2 months. There is improvement in 
the external appearance of genitalia with post-natal 
steroid therapy. 
Maryniak et 
al. (2014) 
33 females ranging 
from 6-23 years old 
from 19 at-risk CAH 
families (17 girls 
treatment prenatally 
with dexamethasone 
(9 affected; 8 non 
affected)) and 16 CAH 
affected females 
prenatally untreated. 
Poland. 
To assess cognitive 
development and social and 
emotional function in girls 
prenatally treated with 
dexamethasone compared 
to female CAH patients who 
were not subjected to 
prenatal therapy 
Mixed 
Methods/Cross 
sectional 
Prenatal treatment with dexamethasone in CAH 
unaffected girls can cause the risk of  unfavorable 
influences on the development of some cognitive 
functions.  
Mathews et 
al. (2009) 
128 participants 
belonging to 1 of 4 
groups: 1. Females 
with CAH 2. 
Unaffected female 
relatives 3. Males with 
CAH and 4. Unaffected 
male relatives ages 
12-44 in the London 
area. Both genders. 
To investigate influences of 
early androgen exposure on 
personality 
Cross sectional/ 
Descriptive 
There are alterations in males and females with CAH in 
some personality facets that show sex differences. 
Females: tendencies to physical aggression and less 
tender minded. Males: less dominant, less rough and 
tumble play, more tender minded. 
Meyer-
Bahlberg et 
al. (2004) 
Dexamethasone 
unexposed girls (15 
with CAH and 30 
without) and the 
dexamethasone 
unexposed boys 
without CAH ages 5-12 
years old in the U.S. 
Both genders 
To test in CAH girls of 
middle childhood the 
assumption that prenatal 
androgens determine the 
development of gender 
identity 
 
Mixed Methods/ 
Descriptive 
Prenatal androgenization female fetuses lead to marked 
masculanization of later gender-related behavior, but the 
absence of any increased gender-identity 
confusion/dysphoria. This concludes that a direct 
determination of gender identity by prenatal androgens 
does not support a male gender assignment at the birth of 
the most markedly masculinized girls. 
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Author 
(Year) 
Sample/Setting Purpose Study Design Conclusions 
Nordenstro
m et al. 
(2002) 
40 females (from 35 
families) with CAH in 
Sweden between the 
ages of 1-10. 
To investigate the possible 
influence of disease severity 
(degree of fetal androgen 
exposure) on toy play and 
toy preference in girls with 
CAH. 
Cross sectional/ 
Observational 
Girls with CAH played more frequently with masculine 
toys than controls. Additionally, the degree of disease 
severity reflected in CYP21 genotype (ie. degree of fetal 
androgen exposure) contributed to the degree of 
masculinization of toy play and preference, with a higher 
degree of fetal androgen exposure correlating to 
increased likelihood of preferring masculine toys. 
 
Ozbey et 
al. (2004) 
70 female patients with 
CAH were counseled 
for gender assignment 
and had reconstructive 
surgery in Istanbul 
Turkey. Girls only. 
To report experience of 
gender (re)assignment in 
genotypical female patients 
with CAH 
Descriptive/ 
Retrospective 
49 were reared as female and 21 as male. Only 9 of these 
“males” could be reassigned as females (mean age 7.87 
months). It is extremely difficult to correct the gender of 
patients with female CAH when they present > 2.5 years 
of age. 
Pasterski et 
al. (2005) 
117 children (34 
females and 31 males 
with CAH; 27 
unaffected sisters and 
25 unaffected 
brothers) ages 3-10 
and parents. Los 
Angeles, USA. 
To assess the toy choices of 
young children with CAH 
and their unaffected siblings 
as well as the parental 
encouragement of sex-typed 
toy play. 
Cross sectional/ 
Observational 
Girls with CAH displayed more male-typical toy choices 
than did their unaffected sisters, whereas boys with and 
without CAH did not differ. Mothers and fathers 
encouraged sex-typical toy play in children with and 
without CAH. Girls with CAH received more positive 
feedback for play with girls’ toys than did unaffected girls. 
Paterski et 
al. (2007) 
113 children (36 girls, 
29 boys with CAH; 25 
unaffected sisters, 21 
unaffected brothers) 
ages 3-11 and their 
mothers from the U.S 
and U.K. Both genders 
To provide more definitive 
information on the effects of 
early androgen exposure on 
aggression and activity level 
by using a larger sample 
than in prior studies and by 
using a standardized 
questionnaire measure of 
current behavior 
Cross Sectional/ 
Descriptive 
Prenatal elevation in androgen that is experienced by 
females with CAH is associated with increased aggressive 
behavior and activity level in childhood. There were no 
significant differences in either aggressive behavior or 
activity level for boys with versus without CAH. 
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Author 
(Year) 
Sample/Setting Purpose Study Design Conclusions 
Pasterski et 
al. (2015) 
153 children total. 43 
females and 38 males 
with CAH and 41 
unaffected female and 
31 unaffected male 
relatives, aged 4-11, 
living in the United 
Kingdom (England, 
Northern Ireland, 
Wales, and Scotland) 
To investigate potential 
cross-gender identification in 
girls exposed prenatally to 
high concentrations of 
androgens due to classical 
CAH. 
Cross sectional/ 
Mixed Methods 
Girls with CAH had more cross-gender responses than 
female controls on all three measures of cross-gender 
identification as well as on a composite measure of 
gender identity independent of gender role behavior. 
Parent report showed 12.8% of the girls with CAH 
exhibited cross-gender behavior in all 5 behavioral 
domains compared to 0% of the children in the other three 
groups combined. The researchers concluded that 
prenatal androgen exposure could play a role in gender 
identity development in healthy children, and may be 
relevant to gender assignment in cases of prenatal 
hormone disruption. 
Servin et al. 
(2003) 
26 girls affected with 
CAH and 26 
unaffected girls ages 
2-10 years in Sweden. 
Girls only 
3 aims: 
1.to replicate and extend 
previous findings of 
masculinization of behavior 
in girls affected by CAH. 
2.to investigate a possible 
relationship between 
disease severity and toy 
play 
3. to explore possible 
parental influences on the 
behavior of the girls 
Cross 
sectional/Observ
ational 
Girls with CAH were more interested in masculine toys 
and less interested in feminine toys and were more likely 
to report having male playmates and to wish for masculine 
careers. Parents of girls with CAH rated their daughters’ 
behaviors as more boy like than did parents of unaffected 
girls. A relationship was found between disease severity 
and behavior indicating that more severely affected CAH 
girls were more interested in masculine toys and careers. 
No parental influence could be demonstrated on play 
behavior. 
 
Woelfle et 
al. (2002) 
16 completely virilized 
females in Germany 
between the ages of 8-
49 years 
To better understand 
specific problems of female 
CAH patients with complete 
virilization and male sex 
assignment 
Cross sectional/ 
Descriptive 
Patients with CAH and complete virilization have a high 
risk of being diagnosed late. There are significant 
negative challenges associated with gender 
reassignment. Gender identity is disturbed in some 
patients. Multiple surgical procedures are necessary and 
challenges with stature and precocious puberty are likely. 
Neonatal screening is of great importance to avoid some 
of these concerns. 
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Author 
(Year) 
Sample/Setting Purpose Study Design Conclusions 
Wong et al. 
(2013) 
The adolescent–adult 
sample included 40 
females and 29 males 
with CAH and 29 
female and 30 male 
unaffected relatives  
age 12–45 years 
recruited from UK. The 
child sample included 
37 females and 
31males with CAH and 
27 female and 21 male 
unaffected relatives 
ages 3–10 years. 
Twenty-nine children 
with CAH and 13 
unaffected relatives 
were recruited in the 
UK and 39 children 
with CAH and 35 
unaffected relatives 
were recruited in Los 
Angeles, USA. 
To assess parental 
encouragement of sex-
typical toy play, as well as 
encouragement of spatial 
activities, in offspring with 
and without CAH. To 
evaluate the relationships 
between parental 
encouragement and 
offspring toy play and spatial 
ability. 
Cross sectional/ 
Observational 
Females with CAH showed more boy-typical toy play and 
better targeting performance than control females, but did 
not differ in mental rotations performance. Males with 
CAH showed worse mental rotations performance than 
control males, but did not differ in sex-typical toy play or 
targeting. Reported parental encouragement of girl-typical 
toy play correlated with girl-typical toy play in all four 
groups.  
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Table 2.3. Summary of Articles: The Lived Experience of Having CAH for Those Affected and Their Families 
 
Author (Year) Sample/Setting Purpose Study Design Conclusions 
Armstrong et al. 
(2006) 
58 parents of 
children age 1 
month -17 years 
with CAH in Hanoi 
Vietnam. Both 
genders. 
To provide more specific insights 
into difficulties faced by families 
with CAH living in Vietnam 
Cross sectional/ 
Descriptive 
A child with CAH is a huge financial concern for 
parents. There is a need for both support groups and 
universal screening. 
Bhakhri & Jain 
(2011) 
28 individuals (17 
males and 11 
females) who are 
parents of 22 
affected children 
aged < 5 years in 
New Delhi India. 
To explore the perceptions and 
misconceptions of parents of 
children with CAH in India 
Cross sectional/ 
Descriptive 
There is a great deal of misconceptions, practices and 
concerns prevalent among the parents of children in 
India affected with CAH. These include gaps in 
knowledge concerning CAH, steroid use, medication, 
and ambiguous genitalia. 
 
Boyse et al. 
(2014) 
4 mothers and 2 
fathers from four 
separate families 
having a child with 
CAH (children’s 
ages were 5-11 
with 2 males and 2 
females). USA. 
To characterize early parent 
caregiver experiences and needs in 
CAH with a focus on contextual 
factors that can be modulated 
through education and support 
delivered by health care providers 
or via the newborn screening 
system. 
Qualitative/ 
Descriptive 
Several themes emerged from the interviews including 
health communication problems, a lack of medical 
home and decision support, and a desire for parent-to-
parent social support.  
de Silva et al. 
(2014) 
37 parents (26 
mothers and 11 
fathers) of children 
(both genders) with 
CAH who attended 
an endocrinology 
center in Sri Lanka. 
To determine the depressive 
symptoms in parents of children 
with CAH 
Cross sectional/ 
Descriptive 
59% of the parents of children with CAH were classified 
as having symptoms of depression, and these 
depressive symptoms did not abate with the passage of 
time. 
Gilban, Alves, & 
Beserra (2014) 
25 patients (age 5-
18 years) with CAH 
in Brazil as well as 
their parents. There 
were 19 female 
patients and 6 were 
male. Among the 
19 female patients, 
2 identified as 
male. Brazil. 
To evaluate the health related 
quality of life of children and 
adolescents with CAH  
Cross sectional/ 
Descriptive 
There is a loss of health related quality of life in children 
and adolescents with classical CAH. The self-
assessment was concordant in key areas with the 
assessment made by their parents. No differences were 
observed between genders or clinical presentation of 
the disease. 
Sanches et al. 
(2012) 
104 parents of 
children with CAH 
age 0-18 years as 
To investigate the physical, social, 
and societal functioning of children 
with CAH and their parents in a 
Cross sectional/ 
Descriptive 
Children with CAH, according to their parents, 
experience few negative effects of the condition and 
they participate well in several areas such as school 
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Author (Year) Sample/Setting Purpose Study Design Conclusions 
well as 24 
adolescents with 
CAH living in The 
Netherlands. Both 
genders. 
Dutch population. and leisure time. Improvements can be made 
concerning the measures parents and children must 
take to prevent an adrenal crisis. 
Yau et al. 
(2015) 
Children with CAH 
(n=33) as well as 
children with 
hypothyroidism 
(n=14) and their 
parents were 
recruited from a 
university based 
pediatric 
endocrinology clinic 
in Los Angeles, 
USA. Both 
genders. 
To evaluate health related quality of 
life in children with CAH and 
investigate whether CAH poses an 
additional burden compared to 
other endocrine disorders. 
Cross sectional/ 
Descriptive 
Compared to subjects with hypothyroidism, children 
with CAH self-reported lower health related quality of 
life in school domain scores. CAH children more 
frequently reported peers not wanting to be friends. 
There was a strong correlation between child self report 
and parent proxy report. 
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Table 2.4. Summary of Articles: Acute Illness, Stress Dosing, and Adrenal Crisis Experiences and Management 
 
Author 
(Year) 
Sample/Setting Purpose Study Design Conclusions 
Fleming et 
al. (2011) 
60 caregivers of children ages 
0-16 with CAH in Los 
Angeles, CA. Both genders. 
To assess caregiver 
knowledge of CAH, 
adrenal crisis, and stress 
dosing and to assess their 
confidence in managing 
adrenal crisis and stress 
dosing of children with 
CAH. Further the 
relationship between 
caregiver knowledge and 
self-efficacy was 
examined. 
Cross sectional/ 
Descriptive 
Caregivers had a good understanding of CAH but those 
that received both a written instruction guideline and a 
demonstration on how to give the hydrocortisone 
injection scored higher on both self efficacy of stress 
dosing and self efficacy of how to give the injection 
Green-Golan 
et al. (2007) 
6 adolescents with CAH ages 
16-20yrs were compared  with 
7 age sex and BMI matched 
controls (16-23yrs) using a 90 
min standardized ergometer 
test. National Institutes of 
Health in Bethesda, MD. Both 
genders. 
To assess hormonal, 
metabolic, and 
cardiovascular response 
to prolonged moderate 
intensity exercise 
comparable to brisk 
walking in adolescents 
with classic CAH 
Cross sectional/ 
Observational 
Patients with CAH have defective glycemic control 
evident in prolonged moderate intensity exercise. CAH 
patients have difficulty maintaining glucose levels as 
exercise duration increases. 
Keil et al. 
(2010) 
 
20 patients with CAH ages 3-
10 enrolled in a long-term 
study at National Institutes of 
Health in Bethesda, MD. Both 
genders. 
Examine blood glucose 
levels and symptoms of 
children with CAH during 
a physical stressor, such 
as a typical acute illness 
managed at home, and 
prospectively determine 
the frequency of 
hypoglycemia 
Longitudinal Children with CAH, despite receiving adequate 
glucocorticoid and mineralocorticoid supplementation, 
are at risk for hypoglycemia during common childhood 
illnesses. 
Weise et al. 
(2004) 
9 adolescent children with 
CAH and 9 adolescent 
children without CAH-done at 
National Institutes of Health  
in Bethesda MD 
To examine whether an 
extra dose of 
hydrocortisone, similar to 
that given during other 
forms of physical stress, 
would normalize blood 
glucose levels during 
exercise in patients with 
CAH 
Cross sectional/ 
Observational 
Patients with classical CAH do not benefit from additional 
hydrocortisone during short-term, high intensity exercise. 
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 PARENTAL MANAGEMENT OF ADRENAL CRISIS IN CHILDREN WITH 
CONGENITAL ADRENAL HYPERPLASIA 
Introduction 
Chronic conditions in children dramatically change the meaning of parenting and 
have varied impacts on family life (Knafl et. al, 2013). Classic congenital adrenal hyperplasia 
(CAH) is a rare, genetic, endocrine disorder that affects approximately 1 in 15,000 live births 
annually (Speiser et al., 2010) and is one such condition. Management of CAH requires 
parents to administer steroids, typically oral hydrocortisone, up to three times daily, 
supplementing maintenance doses with oral “stress dosing” during times of illness and an 
emergency intramuscular (IM) injection of hydrocortisone when a child is unable to tolerate 
oral medications and/or if signs of adrenal crisis are present (Merke & Bornstein, 2005; 
Speiser et al., 2010; Witchel & Azziz, 2011). The need for stress dosing, either orally or by 
injection, related to simple viral and bacterial childhood illnesses is frequent and 
unpredictable, often requiring parents to make complex treatment decisions (Merke & 
Bornstein, 2005). 
Despite the importance of being able to effectively respond to an adrenal crisis 
episode, a 2011 study by the author showed that only half of the 60 parents of children with 
CAH surveyed reported ever having received a demonstration from a health care 
professional on how to administer the emergency injection of hydrocortisone (Fleming, 
Rapp, & Sloane, 2011). Additionally, although parents reported that these children 
experienced adrenal crisis one to two times per year, 39% of parents had not received a 
prescription for injectable hydrocortisone at the time of diagnosis, though that is the 
standard of care (Fleming et al., 2011; Speiser et al., 2010). Moreover, the type of 
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emergency education given to parents by providers, such as written instructions, injection 
demonstration, and when to go to an emergency department of a hospital varied 
considerably (Fleming et al., 2011). Adrenal crisis events are inherently stressful for parents 
and a lack of detailed, ongoing, thorough education from health care providers to parents on 
how to best handle such occurrences increases parental stress regarding ability to respond 
effectively in an emergency (Fleming et al, 2011).  
CAH shares characteristics of episodic, life-threatening crises with other, more 
prevalent, chronic childhood conditions such as type I diabetes, asthma, and anaphylactic 
food allergies (Harris et. al, 2002; Barnard et. al., 2010; Sicherer et. al, 2010).  As with CAH, 
prior research in the pediatric diabetes community suggests that parental fear over times of 
crisis is related to a lack of thorough and repeated education from health care providers on 
how to best handle these crises (Harris et. al, 2002; Barnard et. al., 2010; Sullivan-Bolyai et. 
al, 2010). In a descriptive study of parents of school-age children with diabetes who were 
attending a summer education camp, over half (69%) of parents reported experiencing crisis 
management difficulties such as opening the injection kit and removing the sheath. 
Moreover, approximately a fourth of the parents injected an incorrect dose during simulation 
(Harris et. al, 2002).  
In addition to the life-threatening aspect of CAH, parents must also handle day to day 
maintenance, which includes replacing deficient levels of cortisol and/or aldosterone, while 
attempting to minimize androgen excess, prevent virilization, optimize linear growth (which is 
often compromised) and protect future fertility (Merke & Bornstein, 2005). If a child is 
prescribed too much hydrocortisone, side effects can include growth suppression, obesity, 
and other cushingoid features. If the dose of hydrocortisone is not sufficient, children with 
CAH are at a high risk for precocious puberty, which can also lead to stunted growth and 
adrenal crisis. Determining the proper dosage of steroids is typically achieved by obtaining 
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routine laboratory work and measuring the height, weight and bone age, typically every 3-6 
months, in a growing child (Merke & Bornstein, 2005).  
The aims of this study involve acute management of the condition. They include 
describing circumstances surrounding adrenal crisis events in children with CAH (ie. causes 
and frequency, parental preparation, preparation of others caring for the child); exploring 
parents’ perceptions of the consequences of having a child with a life threatening condition; 
and examining the relationship between parents’ management ability and the impact CAH 
has on the family. 
Methods  
Guiding Framework 
 This study was guided by the Family Management Style Framework (FMSF), which 
provides a structure for understanding family responses to a child’s chronic condition (Knafl, 
Deatrick, & Havill, 2012) (Figure 3.1). The FMSF is grounded in the originators’ research 
and syntheses of studies of family life in the context of childhood chronic conditions. It has 
been used in studies with families exploring the overall response to the child’s condition as 
well as studies of selected aspects of their response (e.g., information management) (Knafl 
et al., 2012). According to the FMSF, individuals in the family contribute to developing a 
family management style or pattern of response that can influence both individual and family 
outcomes (Knafl et al., 2012, Knafl et al., 2013). The framework is comprised of three 
components: definition of the situation (the ways in which the child and child’s condition is 
viewed by the parent(s), management mindset, and parental mutuality), management 
behaviors (parenting goals, strategies, and behaviors linked to caring for a chronically ill 
child), and perceived consequences (actual or expected family, child, and illness outcomes 
that shape management behaviors) (Knafl et al., 2012; Knafl et al., 2013). Table 3.1 outlines 
how the study aims are linked to the FMSF. 
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Design 
This descriptive, mixed methods study was conducted in two phases. In Phase 1, 
parents were asked to complete online questionnaires about selected aspects of their 
experiences of family life in the context of having a child with CAH. In Phase 2, semi-
structured qualitative interviews were conducted to elicit more detailed descriptions of 
parents’ experiences in managing CAH-related crises and their perceptions of how the 
consequences of living with the threat of crisis influenced their child’s and their family’s life. 
The purposive intent of the Phase 2 interview sample was to achieve maximum variation in 
terms of both the demographic profile of families (e.g., parents of boys and girls, families 
having children of varying ages, families from different geographic areas of the U.S, etc.) 
and their experiences managing adrenal crisis events. Scores on the structured measures in 
Phase 1 were also examined so that parents reporting both high and low impact of the 
condition on their family as well as management ability were included in Phase 2. This 
design allowed for comparison and corroboration of the quantitative results with qualitative 
findings (Creswell & Clark, 2010) and provided a rich, comprehensive description of parents’ 
crisis management strategies and their perceptions of the adrenal crisis education they had 
received from health care providers. 
Participants 
 Parents were recruited through the CARES Foundation (CARES), a non-profit 
organization, based in New Jersey, which provides support to families having a child with 
CAH (CARES (Congenital Adrenal hyperplasia-Research, Education, and Support) 
Foundation, 2014). To be included in the study, the parent needed to be over the age of 18, 
English speaking, and have a child between the ages of birth and 18 years diagnosed with 
classic, salt-wasting CAH and free from any other complex health conditions. Furthermore, 
parents needed to have access to a telephone, computer, and email account. A parent was 
defined as a person who lived in the same household with the child and had the 
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responsibility of caring for the child and managing the child’s CAH, even if the parent was 
not the biological mother or father. Recruitment for the study consisted of an “Invitation to 
Participate” letter that CARES emailed to its members who had previously expressed an 
interest in participating in research. In addition, CARES provided a brief description of this 
research study within the research section of their website.  
Measures 
Data were collected through a demographic/family information questionnaire, the 
Pediatric Quality of Life-Family Impact Module (PedsQL-FIM), two scales from the Family 
Management Measure (FaMM)-- View of Condition Impact and Management Ability, and an 
individual semi-structured interview using an interview guide (with each parent participating 
separately). The demographic/family information questionnaire included information about 
the family, the child’s health status, and the frequency of adrenal crisis experience(s). The 
demographic/family information questionnaire was also used to gather data about the 
provider the child saw to manage CAH as well as how and when, if ever, the parent was 
instructed about management of an adrenal crisis. The PedsQL-FIM and the FaMM-View of 
Condition Impact and Management Ability scales provided additional information on the 
effects of living with a child who has a life threatening illness. Varni’s 36-item Peds QL-FIM 
is designed to measure parent self-reported perceptions of the impact of the condition on 
their physical, emotional, social and cognitive functioning; communication; and worry. The 
measure also examines parent-reported family daily activities and family relationships 
(Varni, Sherman, Burwinkle, Dickinson, & Dixon, 2004). In prior studies, the Peds QL-FIM 
internal consistency reliability coefficients have ranged from .82-.97 (Varni et al., 2004). 
Additionally, the 10-item FaMM-View of Condition Impact scale is designed to address 
parents’ perceptions of the seriousness of the condition and its implications for their child’s 
and their family’s future (Knafl et al., 2012). The scale has well established validity and 
reliability. In a study of over 400 families in which a child had a chronic condition, the internal 
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consistency reliability coefficients for the scale were .73 for mothers and .77 for fathers 
(Knafl et al., 2012). The 12-item FaMM-Management Ability scale addresses parents’ 
perceptions of the overall manageability of the child’s condition, including knowing what 
needs to be done to take care of the condition and their ability to competently carry out the 
management of their child’s condition (Knafl et al., 2012). The internal consistency reliability 
coefficients for this scale were .72 for mothers and .73 for fathers (Knafl et al., 2012). Use of 
these measures contributed to a more complete understanding of parents’ perceptions of 
the impact of their child’s CAH on themselves and family life. 
Phase 2 of the study entailed qualitative telephone interviews with the subsample of 
parents who participated in Phase 1. Topics for the interview guide focused on parents’ 
description of their crises management experiences and their perceived competence and 
ability to manage crises based on the three components of the FMSF. (Figure 3.2) 
Data Collection 
Phase 1. In Phase 1, following IRB approval, parents of children with CAH were 
recruited via an email from the CARES Foundation and interested participants then 
contacted the author via telephone, email, or text message. After consent was obtained, the 
demographic/family information questionnaire and the three measures were made available 
to the participants in one document via an online survey using Qualtrics software. Each 
person participating in the survey (including parents in the same family) received a secure, 
individualized electronic link.  
Phase 2. After the survey information was completed and analyzed, a purposive 
sample was generated for Phase 2, and the author contacted the selected parent(s) who 
were willing to be interviewed. When both parents were participating, parents were asked to 
complete the questionnaires separately so that one parent did not influence the other’s 
responses. Each parent in Phase 2  was interviewed separately to provide a full accounting 
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of their individual experiences. Data collection continued during Phase 2 until common 
themes repeatedly emerged to the point of saturation (Bowen, 2008).  
Data Analysis 
  Phase 1. Using the family information questionnaire, descriptive statistics were 
computed for both parents and children including variables such as age, gender, household 
income, as well as examining the timing of when, or if, providers gave parents the 
prescription for injectable hydrocortisone. Then, six separate analyses were done using 
linear mixed models allowing for the variance to be different for fathers and mothers 
(compound symmetry heterogeneous covariance). The first relationship examined was 
between parental management ability and whether providers had demonstrated to parents 
how to give the injection.  The second analysis investigated the relationship between 
parental management ability and child age. Next, the relationship between the impact the 
condition has on the family (FaMM-View of Condition Impact and PedsQL-Family Impact 
Module) and management ability (FaMM-Management Ability Scale) was examined.  
Finally, the relationship between age of the child and the number of adrenal crisis 
events was examined. In the family information questionnaire, parents were asked to 
categorize the number of adrenal crisis events their child had experienced to date (no crisis 
events; 1-2 crisis events; 3-5 crisis events; or 5 or greater crisis events). The lowest number 
in each category was normalized (to obtain a minimum number of adrenal crisis events) with 
the current age of the child (to obtain a minimum number of adrenal crisis events per year) 
and modeled as a function of age less than or equal to five years or greater than five years.  
The age of five was chosen based on several factors including the child beginning school 
and being able to better articulate how they are feeling as well as parental responses when 
asked how their view of the condition has changed over the years in the Phase 2 interviews. 
Then, the relationship between the minimum number of adrenal crises per year and age of 
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the child was modeled as possibly non-linear using adaptive regression (Knafl & Ding, in 
press).  
Phase 2. A professional transcriptionist transcribed the audio recordings verbatim, 
and the transcriptions were checked against the tape for accuracy in an effort to gain a full 
understanding of the tone and emotion elicited from the parents. Following transcription, all 
interviews were coded using a combination of a start list of codes based on the FMSF and 
the online measures and codes inductively derived from interview data. Qualthoyretho 
isitative data analysis was supported using MAXQDA (Verbi Software, 2015), a software 
program that facilitates coding of qualitative data and retrieval of coded material. The 
analysis of interview data first focused on developing a thematic summary of each parent’s 
interview (Ayres, Kavanaugh & Knafl, 2003; Sandelowski, 2011a). In order to balance the 
inherently reductionist nature of coding, a second analytic strategy entailed completion of 
narrative family case summaries of each interview. Case summaries are a useful strategy 
for grounding the analysis of individual codes in the context of the respondent’s overall 
experience (Sandelowski, 2011b). In families where both parents participated, the analysis 
addressed the extent to which parents had a shared or discrepant thematic profile to look for 
varying patterns of family management. Additionally, comparisons were made across all 
parents’ thematic summaries and across all families to provide a greater understanding of 
the nature and range of perceived consequences, for a variety of families, of having a child 
with CAH (Sandelowski, 2011a). Finally, quantitative scores from the measures’ were 
included in the summary matrices for further comparison within and across families based 
on all data sources. Using a within and across case analysis approach (Ayres et al., 2003; 
Sandelowski, 2011a) that included all data sources contributed to a thorough description of 
how participating parents perceived and managed their child’s CAH in the context of 
everyday family life.  
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Results 
Phase 1 Results 
Seventy-seven parents participated in Phase 1 (60 mothers, 2 grandmothers, and 15 
fathers). Of those parents, nine were dyads (8 mother/father; 1 grandmother/father). (Tables 
3.2, 3.3) There was very little missing data; however, certain analyses were computed with 
varying data sets when this occurred. The majority of the parents who participated in Phase 
1 were Caucasian (95%). This is not surprising, as in the United States the incidence of 
CAH is much lower in the African American, Hispanic, and Asian populations (Pass & Neto, 
2009). The mean parent age (n=75) was 41.9 years for mothers and 40.7 years for fathers 
(two grandmothers participated as well-- ages 75 and 44 years);  the mean child age (n=68) 
was 8.4 years. Forty-four parents reported having a girl with CAH (57%) and 33 parents 
(43%) a boy. The parents who participated in Phase 1 lived in 28 states within the U.S. as 
well as four parents from Ghana, Australia, United Kingdom and Puerto Rico, which 
indicates that a large sample of healthcare providers were represented in terms of providers’ 
efforts to prepare parents for managing adrenal crisis events. Of the 73 parents who shared 
household income information, about half (n=36) had a yearly income greater than $100,000 
(US) per year.  
Of the 68 parents who responded to a question inquiring when their child’s provider 
gave them a prescription for intramuscular hydrocortisone, ten parents stated they received 
the prescription one month after diagnosis, three responded between 6-12 months, and four 
stated it took over one year to receive it, meaning that 25% of parents surveyed did not 
receive the prescription within one month of diagnosis, despite that being the standard of 
care (Speiser et al., 2010). How parents perceived providers’ instructions about how to give 
the injection (eg. written guidelines, injection demonstration) varied; however, there was a 
significant relationship (p=.02) between parents having directly been shown by a provider 
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how to correctly administer the injection and higher scores on the FaMM Management 
Ability scale, indicating a stronger ability to manage the condition. 
When examining adrenal crisis event occurrences in Phase 1, there was a 
significant, non-linear relationship between the age of child and the average number of 
adrenal crisis events experienced each year, with the number of crises decreasing over 
time. (Figure 3.3) Parents reported children having 0.77 adrenal crisis events per year (a 
minimum number of one adrenal crisis episode every 1.3 years) in the first five years of life; 
however, after the age of five, parents reported 0.27 adrenal crisis events per year (a 
minimum of one adrenal crisis episode every 3.7 years). There was a significant difference 
in the mean number of adrenal crisis events in children under the age of five and greater 
than or equal to the age of five (p=.01). (Figure 3.3) Additionally, mean ability to manage the 
condition was significantly lower (40.9 v 44.1; p=.009) for parents of children five and under 
compared to parents of children older than five years of age. This indicates that parents feel 
better able to manage the condition as the child gets older.  
Furthermore, when examining parental management ability and the impact the 
condition has on the family using both family impact measures, as management ability 
increased, there was a decrease in the impact CAH has on the family (p<.001). 
Phase 2 Results 
In Phase 2, 16 parents purposively selected from Phase 1 were interviewed, seven 
mother/father dyads and two single mothers.  Of the nine families, four had boys with CAH 
and five had girls with CAH. Ages of the children at the time of the interviews ranged from 2 
years to 15 years, which highlighted varied parent experiences such as school encounters 
and age-dependent child care needs. The parents interviewed were heterogeneous in 
nature when examining demographic variables such as family income, age of the child, and 
where in the United States they resided.  
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Contextual influences on family management. There were multiple contextual 
influences that parents discussed in the interviews that they perceived as affecting family 
management of CAH. These contextual influences included healthcare providers, school 
personnel, babysitters, extended family, and extracurricular activities in which the child 
participated in, primarily sports. 
Interchanges healthcare providers and school personnel. Parents stated that 
although they were satisfied with the relationships they had with their current pediatric 
endocrinologists, providers did not offer support to them emotionally and did not refer them 
to family support groups---local nor national.  
“[The doctor] sat down, and he explained the medical terms of it all  … And then 
basically he re-described the whole scenario to us in terms that I can understand.”   
  
“As far as [providers] being there emotionally, I don’t know if his doctors ever really 
played that role. I think - I just don’t see them – or I can’t site an example where 
there’s the pat on the back or the hug. Nothing like that.”   
 
The management of CAH, especially during times of illness, remains complicated 
and stressful for parents. Although parents reported feeling pleased with their current 
pediatric endocrinologists, parents from five families described not being appropriately 
prepared by their initial providers for adrenal crisis events, which prompted them to change 
health care providers. Parents stated that their current providers have educated them on 
how to administer the emergency injection of hydrocortisone; however, the process had 
been demonstrated only one time by either their pediatric endocrinologists or their staff 
members (ie. nurses, physician assistants, medical assistants). Four parents voiced concern 
that one-time instruction was insufficient in terms of feeling confident in their ability to 
effectively manage an adrenal crisis. 
“They [initial pediatric endocrinologist office] did not demonstrate anything.  They 
actually could not even give us a correct dosage of how much to put in the syringe.  
They gave us a piece of paper that had instructions on it and sent us on our way.” 
 
“We actually asked for it [prescription for injectable hydrocortisone] at our doctor’s 
visit. 
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paper they [pediatric endocrinologist’s office] gave us on how to give it.  So basically, 
we watched a You-Tube video on our own [to learn how to give the injection].” 
 
Consistent with the significant relationship between parents having been shown how 
to given the injection by health care providers and an increased perception of management 
ability in Phase 1, parents who expressed satisfaction in the interviews regarding how their 
providers have prepared them to handle adrenal crisis events described being taught how to 
administer the injection by a nurse or doctor face-to-face. 
 Parents described educating their child’s school nurse or daycare provider on CAH 
and reviewing injection instructions with school nurses on a yearly basis. Overall, parents 
reported favorable experiences with school personnel regarding nurse preparation and 
teacher understanding of the condition; however, several parents describe an often lengthy 
and repetitive process of nurse/staff education as well as anxiety whenever a new nurse 
joined the school staff or when the child changed schools. 
“From very early on when she was getting ready to start a new school, my wife would 
go and make an appointment before school started with the school nurse, bring the 
shot kit and spare meds and all of the other stuff to leave with them in their medicine 
cabinet during the school year.  Bring them a letter that our pediatric endocrinologist 
would write to explain what was going on, warning signs, how to react, who the 
emergency contacts are, that’s been something she’s done you know every year. But 
each time when she has change schools, you know moved up from you know 
kindergarten to first grade to elementary, we have to start all over with the nurse and 
how is that nurse going to respond. But it’s usually gone well.”  
Social network.  
Babysitters. Parents in seven of the families interviewed discussed specific 
management challenges related to times when babysitters were needed for their child with 
CAH. These challenges were related to fear over their child becoming ill while under the 
care of the babysitter, not knowing how much instruction to give the babysitter regarding 
the injection (ie. is a demonstration on how to give the injection necessary?), and 
misgivings that teenage babysitters would be unable to handle an adrenal crisis event. 
Parents stated that they preferred to use family members who had been taught how to 
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respond to a crisis as babysitters; furthermore, they described varying strategies to educate 
babysitters on their child’s condition. 
“I have taught the babysitter how to give the injection.  And I write it down on a piece 
of paper …  like really simple steps if they would have to.  But I would always 
emphasize to just call 911.” 
“This is my son, so if you’re going to be around my son, you’re going to know what to 
do.  You’re going to know what to look for. You’re going to understand. Now what 
might happen to him if I leave the room, if I run to the store, if whatever.  If you’re 
with my child you’re going to know what he has and how to do the basic treatment of 
it.”   
 
Extended family. Parents from six families described their extended families as 
supportive and helpful, especially with regards to child care. However, other parents relayed 
struggles with how their extended families dealt with the diagnosis initially, expressed 
concern over extended family members’ inability to fully understand the challenges 
associated with CAH management, and stated that their families were too afraid to help with 
their child’s care. These struggles created tension within the family. 
 “Some of the other people, like my mom and our friends that watch him for short 
periods of time …  I don’t think they understand the severity of the condition.  They 
just see him, and to them he’s a normal kid.” 
 
“I tried to educate my family and his but they’re just not interested-- they don’t 
understand it.  And I guess me and my husband both have felt a little bit of animosity 
towards them because they don’t. I guess they don’t show the worry or see the 
seriousness in it.  And that’s kind of made us a little bit mad.” 
 
 Extracurricular Activities/Coaches/Sports. Parents in seven families had children who 
were actively participating in at least one school or community based sport including soccer, 
volleyball, hockey, track, and t-ball. The two children not participating in sports were the two 
youngest -- ages 2 and 3. Parents relayed how sports participation was a source of concern 
and described fears that physical exertion might trigger an adrenal crisis; however, parents 
also stated that they wanted their children with CAH to participate in sports because of the 
benefits, both socially and physically, associated with being on a sports team. Parents 
discussed the importance of instructing coaches about the signs and management of a 
crisis. Of the seven children currently playing sports, parents in one family had chosen not to 
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inform the coach about the condition; however, one of those parents brings the emergency 
injection kit to every practice and competition and stays near the child. Parents in only one 
family had instructed their child’s coaches about how to give the injection and confirmed that 
the coach was willing to administer an injection if needed.  
“Because there is a lot of explaining that needs to go on [for the coaches]. We have 
to say if you don’t do the right thing, he’s going to go into a death spiral so it’s a fine 
line.” 
 
 Access to resources. Parents in five of the families reported leaving their initial 
pediatric endocrinologists soon after the time of diagnosis because of dissatisfaction with 
the provider’s level of knowledge about CAH as well as a lack of education on adrenal crisis 
from the provider. Two different mothers stated: 
"Because what I was finding was that it could be fatal if not treated correctly. And the 
endocrinologist we had at the time was not somebody we liked at all and did not 
explain this to us.” 
 
“I didn’t feel like she [the pediatric endocrinologist] had much experience… I think it’s 
rare and there’s not very many cases period.  But she couldn’t put us at ease 
basically.”   
 
For parents in four of the families, this required finding a pediatric endocrinologist in another 
state and a far distance from their homes. Parents reported having to drive long distances to 
see pediatric endocrinologists two to three times per year. 
“Yeah now we’ve been stable now for I think two years with the one we got but we 
still have to drive three and a half hours away [to see new pediatric endocrinologist].” 
 
“There’s not one [a pediatric endocrinologist] –the closest one to us is about three 
hours.  And we did actually start out with that endocrinologist but she started him on 
the prednisolone instead of the hydrocortisone, and he wasn’t growing.  She blamed 
us, said it was our fault and diagnosed him as failure to thrive and pretty much told 
us to prepare ourselves. So I called the CARES Foundation and got a list of good 
doctors, and I made an appointment at Vanderbilt and that’s where we went and we 
just stayed there ever since. It is a 8-9 hour drive.” 
 
Overall, parents detailed certain challenges related to managing the contextual 
influences on the family with regards to their child’s CAH. These included a lack of detailed 
and thorough adrenal crisis preparation from health care providers, repeated adrenal crisis 
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education needs for people in their child’s social network such as teachers, babysitters, and 
coaches, as well as interactions with their extended family related to their child’s condition. 
Definition of the situation. Definition of the situation includes how parents view the 
condition and the child, their management mindset, and parental mutuality (Knafl et al., 
2012). Parents stated certain aspects of their child’s CAH management were going very well 
such as administering daily medication, their child’s current height and weight, and their 
child’s performances in school. All felt that, overall, their child was thriving, happy, and well-
adjusted. However, there were some clear distinctions made by parents between their family 
and others without a child with CAH. For example, the decision for one parent not to work 
outside the home because of the extra attention needed for the CAH child, not allowing 
grade school aged children to play at friends’ houses, and not allowing non-family members 
to babysit were linked to the CAH and described as unique challenges faced by the family. 
When asked what was the most important information to relay to parents having a child just 
diagnosed with the condition, the majority of parents responded that being prepared to 
manage an adrenal crisis event was paramount. 
“So knowing that if you are going to be outdoors on hot summer days you need 
plenty of fluids and salt tablets and you always need to have your shot kit with you. 
You need to know if you’re going to be away from the home all day that you need to 
have all of your different medicines with you. You can’t get caught not prepared for 
the situation.”  
 
 Parents in seven dyads described a strong sense of “being on the same page” 
regarding how they managed their child’s CAH. None of the dyads expressed any 
discrepant management views, nor any significant tension in their relationship related to 
their child’s CAH. Parents described a dramatic difference in how they initially viewed CAH 
at the time of diagnosis and how they viewed it now, with an emphasis on the condition 
becoming easier to manage over time. All of the parents having a child over the age of five 
reported that their view of the condition began to change around the time their child turned 
five years old, which supports the Phase 1 finding that parents find the condition more 
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manageable when their child becomes school age. According to parents, one reason for this 
change in their view of the condition was their child being able to articulate how he/she was 
feeling physically and emotionally. Additionally, by the time the child was four, all of the 
parents had successfully managed an adrenal crisis. At the time of the interview, their 
management mindset was one of confidence. 
“Now we know what to look for more.  We know the signs and symptoms [of adrenal 
crisis]… like when she was a baby we didn’t know what it would look like.” 
 
“In the first few months [after diagnosis] it was trying to understand it.  It was 
educating.  It was learning about it.  It was researching.  It was trying to understand 
how it happened, why it happened … The first couple of years were the roughest but 
as he’s grown and gotten better, it is easier.”  
 
Parents in all nine families had experienced an adrenal crisis event, with parents in 
eight of the nine families describing multiple crisis episodes. Parents acknowledged that 
these life threatening events contributed greatly to how they viewed the illness and their 
management capacity. Parental accounts of adrenal crisis episodes were most often linked 
to gastrointestinal illnesses involving repeated vomiting as well as trauma related to 
accidental injuries related to outdoor activities. Adrenal crisis events were described as 
inherently stressful, and parents stated that knowing that their child could die if their 
response was not effective was both overwhelming and terrifying. 
“And the doctors would explain to you ‘Now he’s not going to die as long as you just 
do what you’re supposed to do.’” 
 
“It [adrenal crisis event] was the most terrifying thing I’ve ever experienced.  It was 
because we did not have all of the information, so we weren’t prepared.” 
 
“One day my wife and him they were outside, and he was playing normal and fine.  
He wasn’t sick, he didn’t have a cold, he didn’t have anything that would have 
caused it. He was running across the yard and the next thing you know he was face 
down in the yard.” 
 
With few exceptions, parents labeled their child’s life and their family life as “normal,” 
and the parents that were partnered described a strong sense of agreement in their 
approach to managing the condition. Over time, parents developed a daily routine for 
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condition management that they viewed as manageable. However, during illness and 
adrenal crisis, there were management challenges, and during these times, the parental 
view of the condition and the child would temporarily change 
Management behavior. The Management Behavior Component of the FMSF 
includes parenting philosophy and management approach, including management routines 
(Knafl et al., 2012). Parents described daily management of CAH as relatively 
straightforward, consisting of giving their child oral steroids two to three times a day. 
However, four dyads described a highly structured routine that could not be compromised in 
any way when discussing the exact timing of administering the medication. 
“Going back to us being super science-based we’re very, very strict on like eight 
hours, her medication every eight hours.  So we do follow this one hundred percent, 
and she has her medication at like eight, four and midnight.”  
 
Across families, one parent, either the mother or the father, was usually responsible 
for daily management including medication administration, communicating their child’s 
special health needs to others in their child’s social network, and taking their child for 
healthcare provider visits. However, both parents reported being trained and capable of 
giving the hydrocortisone injection when needed. Although parents in the seven dyads 
described a shared view of the condition, several parents expressed that they felt they and 
their partner had differing management approaches. For example, regarding stress dosing 
and giving the IM injection, one parent might feel more anxious and take the “better safe 
than sorry” approach of giving the stress dose, while the other parent was more willing to 
“wait it out;” however, none of the parents described this as a source of significant conflict. 
“I’d say when it comes to time … when he gets a little bit sick, sometimes she’ll get 
into a mentality of ‘oh it’s not that big of deal,’ and I have a much quicker trigger 
finger. I am ready to start stress dosing.” 
 
“He constantly worries. He is just always worried about what we did [stress dosing]. 
I’m more like, well, I always felt like we could get him help you know what I mean?  
There are hospitals everywhere is how I feel.  But he’s like, he’s very anxious.” 
 
	
	
	 68 
Regarding parenting philosophy, every parent interviewed discussed making a 
conscious choice to treat their child normally and not unnecessarily restrict activities 
because of the condition. They also described their family life in general as similar to that of 
other families. 
“I think it’s extremely important to make these children feel that they’re really not that 
different. That everybody has something and this happens to be what you have, what 
your child has.  And they can do anything they want to do you shouldn’t limit them.” 
 
Perceived consequences. Perceived consequences are the extent to which family 
life is focused on the child and future expectations for the child and how the family is viewed 
as linked to the condition (Knafl et al., 2012). Parents described how efforts to incorporate 
CAH management as part of the usual family routine were successful; however, 
unpredictable, acute illnesses and the possibility of adrenal crisis could dramatically disrupt 
that routine. Parents remained hopeful regarding their child’s future, but also expressed 
concerns for their child’s health and wellbeing in regards to puberty/adolescence as well as 
their anticipation that they would have less control over the treatment regimen and response 
to crises as the child becomes a young adult. 
“My expectation is she’s going to have a normal life.  And she’s got a pretty good 
head on her shoulders.” 
 
“We all worry about him being by himself or somebody not knowing he’s sick or not 
knowing what’s going on and that bothers me.  I think I want him to live next door to 
me.” 
 
“Yeah and I think about that when she goes to college, you know?  Is she going to 
be equipped? Are the medical centers going to be equipped if she gets hurt or if she 
drinks too much and she’s vomiting the next day?  You know I think about those 
things.” 
 
Parents in eight of the nine families interviewed had children other than their child 
with CAH child. When asked, parents stated they felt CAH had minimal impact on the 
siblings; however, parents also noted that siblings experienced distress during a CAH crisis. 
Parents expressed concern that some of the events experienced by siblings, especially 
related to paramedics at the home and hospitalizations of the child with CAH, would be long 
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lasting negative childhood memories for siblings. Additionally, parents in three families 
stated that siblings exhibited jealous behavior regarding the extra attention that CAH 
children received because of special care needs, illness, or crisis. 
Finally, for some parents, having a child with CAH resulted in challenging 
reproductive decisions. Six parents interviewed described making a decision to not have 
other children after their CAH child because they did not feel capable of managing the care 
of more than one child with an episodically life threatening condition. Parents in one family 
did have subsequent children, but opted for prenatal treatment of dexamethasone (the baby 
she was carrying was a girl) in an effort to prevent virilization, while parents in another family 
chose to have another child but not take dexamethasone and knowingly risk having another 
girl with possible virilization. Parents in another family chose to do a pre-implantation genetic 
diagnosis to determine if CAH was present in any of the embryos produced through in-vitro 
fertilization prior to implantation in an effort to ensure their subsequent child did not have the 
condition. A recurrent theme concerning the perceived consequences families having a child 
with CAH experience involves planning. Family planning after having one child with CAH, 
planning for potential adrenal crisis events, and planning for their child’s health and safety 
as they grow into adolescents and young adults are all important issues and decisions for 
these families. 
Discussion 
This study provided evidence that over time parents adapt to the management 
challenges of having a child with CAH, but the threat of a crisis remains an ongoing concern. 
Parents believe that their children are, for the most part, living normal lives despite having 
CAH; however, living with the uncertainty of an adrenal crisis is challenging for parents, 
especially in the context of not being properly prepared by healthcare providers to manage 
adrenal crisis events. When parents are not properly prepared on how to manage the life 
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threatening aspects of CAH, the result can be a reliance on EMS services and emergency 
departments to manage crisis events. Due to the need for an immediate effective response 
to the signs and symptoms of adrenal crisis, this reliance on outside emergency services 
can lead to serious injury and possible death of the child if the response is not swift or 
treatment is misunderstood. Additional stressors for these families include finding 
appropriate child care, which includes care providers trained to give a hydrocortisone 
injection, as well as feeling emotionally unsupported by health care providers. The CAH 
child’s social environment such as school, daycare, and extracurricular activities also 
produce challenges regarding parental fear of adrenal crisis episodes when they are not 
present. 
Understanding and identifying gaps in parent education by healthcare providers, 
especially concerning times of adrenal crisis, is necessary to promote positive family 
outcomes, both from an emotional standpoint as well a child health perspective. Provider 
support is needed for these parents throughout childhood, but especially in the first five 
years of life when parents are adjusting to having a child with a life-threatening condition 
and children frequently acquire common childhood illnesses that require stress dosing of 
hydrocortisone as well as associated hospitalizations (Rushworth et al., 2016). Developing 
interventions that encourage appointments with health care providers to include a focus on 
the nonmedical aspects of life with CAH in an effort to increase emotional support from 
providers to families is needed. For example, regular appointments and check ups with 
providers should include discussions about how families are handling the child’s extra-
curricular activities, school environment, height and weight difficulties, and child care when a 
parent is unavailable, as these are all aspects of CAH management that have the potential 
to disrupt family life. Additionally, detailed and uniform education from providers on how to 
effectively handle adrenal crisis episodes has great potential in preventing costly emergency 
room visits and providing peace of mind to caregivers of children with CAH.
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Table 3.1. Outline of Study Aims and FMSF 
 
Aim of the Study Component of 
Framework 
Topic(s) of Interest Data Collection 
Method 
Describe circumstances 
surrounding adrenal crises in 
children with CAH by examining: 
 
1.1) Parents’ perceptions of the 
experience (e.g., what they did, 
how they used information) 
1.2) Parents’ descriptions of 
sources (e.g., education from 
healthcare professionals, support 
groups, internet, etc.) of 
information related to managing 
times of crisis; 
1.3) Strategies and approaches 
parents used to inform other family 
members (siblings, grandparents, 
etc.), school personnel, and others 
in their social network (friends, 
babysitters, etc.) on how to 
manage adrenal crises about 
adrenal crisis management 
including parents’ perceptions of 
their effectiveness 
 
Definition of the 
Situation, 
Management 
Behaviors 
Parental perceptions and 
interpretations of adrenal crisis 
events and their beliefs about 
their ability to manage the 
event 
 
Parents’ assessment of the 
extent to which they have an 
established approach for 
responding to an adrenal crisis 
and their strategies for 
accessing and conveying 
information about crisis 
management 
Semi-structured 
Interview; Family 
Management 
Measure – View 
of Condition 
Impact and 
Management 
Ability Scales; 
PedsQL-Family 
Impact Module 
Explore parents’ perceptions of the 
consequences, for their child with 
CAH, themselves, and their family, 
of living with the possibility that 
their child with CAH will experience 
a life threatening crisis 
 
Perceived 
Consequences  
Parents’ perceptions of the 
ways in which the life 
threatening nature of the 
condition affects everyday life 
for their child and family  
Semi-structured 
Interview; Family 
Management 
Measure – View 
of Condition 
Impact and 
Management 
Ability Scales; 
PedsQL-Family 
Impact Module 
 
Examine a possible relationship 
between parents’ management 
ability and the impact CAH has on 
the family  
 
Definition of the 
Situation, 
Management 
Behaviors, 
Perceived 
Consequences 
The relationship between 
parents’ management ability 
and the impact CAH has on the 
family (e.g. does increased 
ability to manage CAH lead to 
decreased impact of the 
condition on the family?) 
Semi-structured 
Interview; Family 
Management 
Measure – View 
of Condition 
Impact and 
Management 
Ability Scales; 
PedsQL-Family 
Impact Module 
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Table 3.2. Phase 1 Parent Participant Characteristics 
 
Parenting Role n (%) 
     Mother  60 (78) 
     Father 15 (19) 
     Grandmother 2 (3) 
  
Racial Identification n (%) 
     American Indian/Alaskan Native 1 (1.3) 
     Asian 2 (2.7) 
     Black 1 (1.3) 
     Hawaiian/Pacific Islander 0 
     White 71 (94.7) 
  
Ethnicity n (%) 
     Hispanic 4 (5.3) 
     Non-Hispanic 72 (94.7) 
  
Yearly Family Income n (%) 
     <$50,000 10 (13.7) 
     $50,000-80,000 12 (16.4) 
     $80,000-100,000 15 (20.6) 
     $100,000-150,000 14 (19.2) 
     >$150,000 22 (30.1) 
  
Age of Mother  
     Mean (SD) 41.98 (7.4) 
     Range 26-54 
  
Age of Father  
     Mean (SD) 40.71 (4.9) 
     Range 33-47 
  
Age of Grandmother  
     Mean (SD) 59.5 (21.9) 
     Range 44-75 
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Table 3.3. Phase 1 Parent Reported Child Characteristics 
 
Racial Identification  n (%) 
     American Indian/Alaskan Native 1 (1.3) 
     Asian 2 (2.7) 
     Black 1 (1.3) 
     Hawaiian/Pacific Islander 0 
     White 71 (94.7) 
  
Ethnicity  n (%) 
     Hispanic 6 (7.9) 
     Non-Hispanic 70 (92.1) 
  
Wears Medical Alert Tag n (%) 
     Yes 51 (66) 
     No 26(34) 
  
Gender of Child n (%) 
     Male 33 (43) 
     Female 44 (57) 
  
Age of Child  
     Mean (SD) 8.4 (5.3) 
     Range 1 month-18 years 
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Figure 3.1. Family Management Style Framework 
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Contextual 
Influences on 
Family 
Management 
 
 
 
Definition of the Situation 
 
 
Management 
Behavior 
 
 
Perceived 
Consequences 
 
Care providers; 
Resources; 
Social support; 
Community 
 
View of the condition; 
Choice to live a “normal” 
life; Management mindset; 
Parental mutuality; 
Uncertainty in times of 
acute illness 
 
Parenting 
philosophy; 
Management 
approach 
 
Family focus; Future 
expectations; 
Family planning 
 
Figure 3.2. Data codes and major components of FMSF 
  
	
	
	 76 
 
Figure 3.3. Phase 1-Minimum Number of Adrenal Crisis Episodes and Age of the Child 
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 GENDER MATTERS IN FAMILIES HAVING A CHILD WITH CONGENITAL 
ADRENAL HYPERPLASIA 
Overview 
Congenital adrenal hyperplasia (CAH) is an inherited, endocrine disorder that occurs 
in approximately 1 in 15,000 live births and affects males and females equally (Speiser et 
al., 2010). Both boys and girls born with CAH are exposed to high concentrations of 
androgens in utero; while boys typically do not show any outward physical signs of this 
exposure (except possibly subtle hyperpigmentation and penile enlargement), girls often 
have ambiguous genitalia to varying degrees, which typically leads to a diagnosis in girls 
shortly after birth (Witchel & Azziz, 2011). The degree of virilization is graded according to 
the Prader score (with a 0 appearing as a typical female and a 5 appearing as a typical 
male). Gender assignment in these affected females can pose both a medical and family 
crisis (Merke & Bornstein, 2005; Speiser et al., 2010). A surgical procedure called 
reconstructive feminizing genitoplasty is recommended by some providers at an early age 
and can involve multiple surgeries into adolescence (Witchel & Azziz, 2011; Karkazis, 
2008). Although girls with CAH identify as female (Berenbaum & Bailey, 2003; Dessens, 
Slijper, & Drop, 2005), they often show increased preference for male toys and activities 
(Nordenstrom et al., 2002; Pasterski et al, 2005; Wong et al., 2013), increased aggression 
(Pasterski et al., 2007; Mathews et al, 2009), increased male-typical sexual orientation 
(Nordenstrom et al., 2010), and differences when compared to non-CAH girls in spatial 
abilities (Hines et al., 2003; Berenbaum et al., 2012). 
All children with CAH are at significant risk for adrenal crisis, defined as an abrupt, 
life-threatening state with symptoms including hypotension, pallor, fatigue, headache, 
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tachycardia, and vomiting, due to steroid deficiency (Speiser et al., 2010). Parents must 
administer steroids, typically oral hydrocortisone, up to three times daily to replace deficient 
levels of cortisol, and “stress dose,” meaning give additional oral steroid doses or an 
intramuscular injection of hydrocortisone, during times of acute physical illnesses due to 
common viral and bacterial causes as well as during surgeries or traumas. Despite the 
complex nature of CAH management, both during times of maintenance and emergency, as 
well as the unique struggles that girls born with CAH and their families can experience, very 
few studies have explored the impact CAH has on families in which a daughter has the 
condition. 
The purpose of this analysis, which draws on data from a larger, mixed methods 
study, was to examine, based on the gender of the child, the varying family experiences of 
having a child with CAH. This cross-sectional, qualitative study was the second phase of a 
larger mixed-methods (phase 1, quantitative; phase 2, qualitative) study conducted by the 
primary author. The purposes of the larger study were to examine parental management of 
adrenal crisis in children with CAH as well as the consequences of having a child with a life 
threatening condition; however, during the qualitative, Phase 2 portion of the study, it 
became evident that certain aspects of the family experience of having a child with CAH 
were profoundly different based on the gender of the child.  
Methods  
Participants 
 In order to be included in the study, the parent needed to be over the age of 18, 
English speaking, and have a child between the ages of birth and 18 years diagnosed with 
classic, salt-wasting CAH and free from any other complex health conditions. Furthermore, 
parents needed to have access to a telephone, computer, and email account. Parents were 
recruited through the CARES Foundation (CARES), a non-profit organization, based in New 
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Jersey, which provides support to families in which there is a member with CAH (CARES 
Foundation, 2014). Recruitment for the study consisted of an “Invitation to Participate” letter 
that CARES emailed to its members who had previously expressed an interest in 
participating in research. In addition, CARES provided a brief description of this research 
study within the research section of their website.  
Sixteen parents, seven mother/father dyads and two single mothers, were 
successfully contacted and agreed to participate in the qualitative portion of the study. There 
were five families having a girl with CAH and four having a boy. Child age ranged from 2-15 
years and geographical location, family income, marital status of the parents, and scores on 
the Phase 1 quantitative measures examining family management ability and impact of the 
condition, varied. All of the parents that were interviewed and their children were Caucasian. 
In the United States, the incidence of CAH is much lower in the African American, Hispanic, 
and Asian populations (Pass & Neto, 2009). 
Analysis of Data 
A professional transcriptionist transcribed the audio recordings verbatim, and the 
transcriptions were reviewed multiple times to get a broad understanding of the content. 
MAXQDA (VERBI Software, 2015), a qualitative software program, was used to aid with the 
coding and retrieval of coded data. Directed content analysis was used to identify 
descriptive and/or conceptual categories to organize the inquiry (Vaismoradi, Turunen, & 
Bondas 2013). Comparisons were made across all themes reflected in the parents’ 
interviews to provide a richer understanding of the impact having a child with CAH has on 
the family (Sandelowski, 2011). Data collection continued until common themes repeatedly 
emerged to the point of saturation (Bowen, 2008; Morse, 2015). During the analysis of the 
interviews in Phase 2, it was noted that the way parents viewed the condition and the impact 
CAH had on the family differed based on the gender of the child, and additional investigation 
ensued examining these variations. 
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Findings  
There were some clear and important distinctions in the family experiences of 
parents of boys and girls with CAH. Of the 16 parents from nine families interviewed, five 
had a girl with CAH ranging in age from 2-14, and all five girls were born with ambiguous 
genitalia. These parents, four mother/father dyads and one single mother, detailed 
experiences much different than the four families having a boy between the ages of 3-15. 
These differences included parents’ descriptions of the time of diagnosis, their accounts of 
challenging surgical, treatment-related decisions (feminizing genitoplasty), and a sense of a 
pervasive stigma surrounding CAH. 
Timing of Diagnosis 
For boys, the CAH diagnosis was made within two weeks of birth, after the child had 
been discharged from the hospital setting, via newborn screening. Three boys were 
diagnosed within ten days of being born. One boy was born in a state where newborn 
screening wasn’t done at the time of his birth and was diagnosed after a month of age. 
Parents of boys reported feeling shocked and devastated when hearing of the diagnosis. 
None of the parents of the boys stated they were dissatisfied with the manner in which 
health care providers informed them of the diagnosis. 
“I guess the very first thing was the newborn screening.  I remember vividly the day.  
I remember exactly what I was wearing.  What I was doing.  It shattered our whole 
world basically.” 
 
“[After diagnosis] It was educating.  It was learning about it.  It was researching.  It 
was trying to understand how it happened, why it happened …” 
 
Whereas the parents of boys first learned that their child had CAH after their son had 
been discharged from the hospital, parents of girls experienced an extended hospital stay 
after birth because of the child’s ambiguous genitalia and learned of the condition during the 
hospitalization. Providers suspected a diagnosis of CAH or some other condition from the 
beginning, and these parents stayed in the hospital with their daughters until a definitive 
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diagnosis was made. For parents of girls, the news was somewhat of a relief, as parents 
were searching for reasons as to why their daughter had ambiguous genitalia and had 
concerns over other possible explanations. The news of CAH provided an answer after 
several hours or days of confusion, which was welcomed. 
“So when she was first diagnosed I think that I was…I was relieved mostly. The 
testing confirmed that the condition was something that the doctors understood and 
that it was something that could be treated.” 
 
“We knew something was wrong the minute she was born because of the very 
ambiguous genitalia. It was a whirlwind five days in the NICU where she was 
misdiagnosed as a male instead of a female until we got our test back and 
everything was verified.  It was pretty crazy.”   
 
 Four families of girls expressed frustration with the way in which the healthcare 
providers in the delivery room (obstetricians, nurses, pediatricians, nurse midwifes) as well 
as pediatric endocrinologists responded to and explained their daughters’ ambiguous 
genitalia. Two mothers stated that, despite hearing their daughters’ immediate afterbirth 
cries, providers refused to allow them to see their babies, leaving them in extreme distress 
and confusion.  
“I just wanted the baby on my chest and somebody to just like cut the crap and tell 
me what was going on.  And I said, ‘okay that’s fine can I have the baby?  Like can 
you just bring the baby?  It doesn’t have like any immediate medical needs can I 
have the baby?’”   
 
“They [healthcare providers] seemed to be much more preoccupied about her 
genitalia in a way that my partner and I absolutely were not...  So it was really 
intimidating.  And you know I just had a baby.  I was feeling awful and it was, you 
know, a pediatric gynecologist, a pediatric social worker, pediatric psychologist….” 
 
Only one family was satisfied with the way providers shared the news of their 
daughter’s diagnosis. The father remembers this positive encounter: 
“He could tell by doing some sonograms what the internal physiology was because 
the outside physiology could have gone either way...  He said it could be – it was 
ambiguous enough that he could not make a call from that.  So they set up, even on 
a Sunday morning, they set up the sonogram for us. It was probably like around nine 
thirty, ten o’clock in the morning, with a big smile on his face and said you have a 
beautiful, healthy daughter and this is what we need to do.” 
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All five of the parents were told that their child’s gender was uncertain immediately 
after birth, but the terminology varied. For some parents, the terminology used to describe 
their daughter from the midwife in the delivery room was painful and traumatizing. 
“My husband is in the room, and our nurse takes a peek and says it’s a boy! Then 
the midwife turns her over, looks at me and says ‘I’m not so sure.’ The NICU doctor 
and my midwife turned to me and said ‘we need to talk about the white elephant-- 
that this child might be a “hermaphrodite.”’ Oh my God! It was awful, the shock. All I 
could think was “hermaphrodite.” I’m lying in the hospital thinking can I raise this 
baby? It was so traumatic.” 
 
A father added: 
 
“One of the things one of the nurses said when my daughter was first born  …  We 
thought maybe she was a boy and then like one of the nurses was like, ‘oh maybe  
this is a transvestite?’  And you hear that and you’re like, really?” 
 
 Following the diagnosis and within the first month, parents of boys did not report any 
concerns regarding telling family and friends of their child’s birth and condition. Most 
described extended family as an initial source of support providing childcare for the baby 
and/or siblings as well as accompanying the parents to doctor appointments.  However, for 
families having a girl with CAH, the experience of who to tell after their daughter’s birth was 
much more complicated. Parents explained that deciding whether or not to tell friends was 
difficult, as they were concerned that as their daughter grew, she might feel uncomfortable 
with others knowing that she was born with ambiguous genitalia. One father stated that he 
didn’t tell certain family members about his daughter’s ambiguous genitalia initially because 
he felt like they would never change her diaper so they didn’t need to know. A mother 
described not wanting to announce the birth of her daughter on social media because she 
was unsure at that time if her child was a boy or a girl. Keeping the birth so quiet for the first 
week, especially when family and friends knew she had gone to the hospital to have the 
baby, was very stressful and awkward for her and her husband and created an environment 
of secrecy regarding an occasion that she thought would be joyous and open.  
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“But talking about the ambiguous genitalia with our friends and family… pretty much 
we decided in the beginning we would not tell everybody because what if she didn’t 
want anyone to know?” 
 
For parents of girls, the way the condition was initially described to them by 
healthcare providers was, for the most part, traumatizing and began to shape the way they 
viewed CAH. A prolonged hospital stay combined with confusion over the condition and 
stigmatizing language differentiated the time surrounding the diagnosis of CAH for parents 
of girls versus boys. 
Surgical Decisions 
Of the five families having a daughter with ambiguous genitalia, parents in four 
families decided in favor of surgical intervention within the first year. The goals of feminizing 
genitoplasty are to facilitate genital appearance compatible with gender, relieve urinary 
obstructions that result in episodes of incontinence and infections, and to preserve adult 
sexual and reproductive function (Speiser et al., 2010). All parents described this as a very 
difficult decision, although none of them currently expressed regret. One mother and father 
of a teenage daughter who has had two surgeries to date and continues to require daily 
vaginal dilating interventions at home stated: 
“We talked about it … we went over it a million times in our head and we said you 
know she may hate us for it later, but we feel this is the best decision we can make 
for our child.”   
 
The mother went on to describe how she and her husband explained the decision to have 
the surgery to their daughter: 
“We told her about her surgery and the reason she had it primarily was because her 
urethra and her vagina were fused together and there was some backflow causing 
infections.  She knew about that from pretty early on.  We’re very upfront with her.  I 
can’t tell you when we told her but I know it’s been early and it’s been an open 
conversation.” 
 
Another mother of a pre-teen daughter with CAH explained that her and her husband voiced 
their concerns regarding trying to preserve later sexual function to their daughter’s pediatric 
urologist. 
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“We, you know, had read about the doctors that focused more on the aesthetic of it 
and then these … children grow up and don’t have the nerve endings there because 
they were cut to make it look perfect and they have no sexual satisfaction. So we 
expressed to him several times, and got our point across, that we wanted her to look 
normal, but we wanted her to have sexual satisfaction. 
 
Finally, another mother of a teenage daughter with CAH shared that although she was 
currently satisfied with the results of the surgery from a cosmetic standpoint, her daughter 
had undergone three surgeries and will need at least one more. These surgeries were 
extremely stressful for this mother and contributed to her decision not to have any more 
children. 
“Oh yeah it’s really been a struggle for me. I’m not the same person, but it was worth 
it to me.  It was absolutely worth it. I was a wreck.  She had to be put to sleep a total 
of three times for that.  Each time I thought I was going to lose my mind with worry so 
I couldn’t do that again.” 
 
One family of a three year old girl made the decision not to have feminizing 
genitoplasty. Both parents agreed that it was better to wait until their daughter could make 
the decision as to whether or not to have surgery on her own. They felt strongly that there 
were too many potential problems later in life related to genital surgery and believed that 
waiting until their daughter was a young adult and could make an informed decision herself 
was a better approach. They were disappointed in the way in which their daughter’s initial 
pediatric urologist explained the surgical option to them. 
“He said ‘well you know this is just the time to do it.’  And I said wouldn’t you have to 
have like revisions later?  And he said ‘yeah but, you know, it’s better now.’ 
He ended up like kind of divorcing us from his practice because we kept saying no to 
surgery, and he said ‘well fine then we’ll see you in five years.’” 
 
These parents went on to explain that, for their daughter, there was no medical reason to 
have the surgery. Therefore, it was frustrating and upsetting to them that they felt the 
medical team did not honor or respect their opinion to forego the procedure, at least until 
their daughter was older.   
“Unless there is a medical reason like she was having  …  which I don’t foresee, I 
would never touch her genitalia because she might need it …  I don’t know. I think 
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it’s a challenge because you kind of could delay some of these things until even like 
five or six or when your kid can articulate what they’re feeling, you know?” 
 
The decision of whether to or not to have reconstructing feminizing genitoplasty is  
complex and challenging for parents. A lack of support from providers at the time of the 
decision as well as follow-up support is evident.  
Stigma 
Parents of both boys and girls with CAH described experiencing some degree of 
stress and stigmatization involving their child’s condition. Wearing a medic alert tag 
identifying their child as “different,” taking medication during school hours, and having to 
explain a rare condition that is complex to manage to others in their child’s social circle were 
mentioned by all parents. However, the stigma for families having a daughter with 
ambiguous genitalia was pervasive and intense and contributed to how these families 
viewed CAH in general. 
“We decided in the beginning we would not tell everybody because what if she didn’t 
want anyone to know?  But then we thought that kind creates an atmosphere that 
there’s something wrong if we keep it a secret …”  
“We don’t want to create a freak show environment … where people are talking 
about it all the time because people don’t really talk about their own genitalia all the 
time. So we kind of want to normalize it, and it’s really hard to know how to do that. 
… There’s nobody to ask.” 
 
 When parents of both boys and girls were asked what they felt the most important 
topic to discuss at a support group meeting for families having a child newly diagnosed with 
CAH, parents of the boys overwhelmingly focused on preparation for times of illness and 
adrenal crisis. Parents of girls mentioned this as well, but focused heavily on trying to 
normalize, gender identity, and handling stigma. The life-threatening aspect of CAH appears 
to be something that parents of girls are clearly aware of and concerned about, but view as 
something that is clear-cut and manageable, which is distinctly different than parents of 
boys. Parents of girls described potential adrenal crisis events as somewhat in the 
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background of daily life. For these parents, issues related to ambiguous genitalia were the 
predominant concern. 
“How to deal with the ambiguous genitalia is something that’s very much on-going 
and not as cut and dry as the adrenal condition as it stands because we’re sort of  
constantly running this risk of providing private information about our child.  You 
know we can’t un-tell people.  On the other hand we’re also cognitive of the fact that 
there’s nothing to be ashamed about this condition and we have to treat it like we 
would treat anything else. There’s nothing to be ashamed of.” 
 
Additionally, several parents of girls described stress dosing or giving the injection during 
times of illness as daunting, but easier to manage and explain to others when compared to 
ambiguous genitalia. For stress dosing, there are clear treatment guidelines such as tripling 
the oral dose if their daughter has a high fever but there were few, if any, guidelines for 
parenting a child with ambiguous genitalia. On the other hand, parents of boys all remarked 
on how the fear of adrenal crisis has impacted family life and shaped their view of the 
condition.  
 Finally, whether or not society would accept and understand their daughter’s past 
and/or present ambiguous genitalia was unknown to parents and described as a major 
worry. This concern was evident from birth for parents of girls and is reflected in their 
hesitancy to announce the birth, share information about the diagnosis, and in deliberate 
attempts by parents to protect their child from possible embarrassment or ridicule (Sanders 
et al., 2012).  
“We were somewhat beholding to how mean kids can be, and you know not wanting 
her to ever have to deal with it in a locker room or whatever.”  
 
“I don’t know who this person was [on Twitter], but the person he was talking about 
was a transgender, and he called her the face of Congenital Adrenal Hyperplasia.  
And I remember being so angry I almost tweeted back at him. I didn’t know what to 
say.  I decided to put down the computer and walk away.”   
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Discussion 
Rare childhood conditions, such as CAH, are often misunderstood, which can create 
isolation and stress for those affected as well as their families (Zurynski, Frith, Leonard & 
Elliott, 2008; Dellve, Samuelsson, Tallborn, Fasth, & Hallberg, 2006).  Family-related 
challenges such as access to care, stress during times of acute illness, and school and work 
disruptions also contribute to parental feelings of loneliness and exclusion (Zurynski et al., 
2008). Families having a daughter with CAH experience significant, additional challenges 
associated with the condition when compared to families having a son with CAH. These 
include the fear of intense stigmatization, challenging surgical decisions, and concerns 
regarding disclosure to others of their daughter’s condition. 
The initial time period following the diagnosis of CAH, whether that is in the delivery 
room or by a newborn screening days later, produced varied parental responses based on 
the gender of the child. How the child’s condition is initially portrayed to the family from 
healthcare providers is critical in shaping the lens through which the family views the 
condition. For parents of girls with CAH, the view of the condition begins to emerge shortly 
after birth and can be related to healthcare providers’ responses to the condition and 
associated ambiguous genitalia and what terminology is used to communicate the diagnosis 
to parents. Several parents interviewed voiced disappointment over the way healthcare 
providers responded to their daughters’ genital appearance and the language providers 
used as they discussed differential diagnoses.  
Seven out of nine parents having a daughter with CAH who were interviewed 
expressed concern and disappointment regarding how healthcare providers discussed their 
daughters’ ambiguous genitalia. This echoes concerns raised by patient advocacy groups in 
the last ten years over the use of terms such as “intersex,” “pseudo hermaphroditism,” and 
“hermaphroditism.” Recently, these terms have been replaced in the medical community, 
particularly in Europe, by the more acceptable term of disorders of sex development (DSD) 
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(Pasterski et al., 2010; Hughes, 2008). The intent in changing this nomenclature was that 
the term DSD would be both medically appropriate as well as sensitive to needs of the 
patients and parents (Lin-Su, Lekarev, Poppas & Vogiatzi, 2015). A large number of CAH 
patients, parents, and other relatives of patients with CAH were surveyed on their response 
to the term DSD last year (Lin-Su et al., 2015). Although DSD was developed with a primary 
objective of better representing affected individuals, most surveyed believed DSD had a 
negative effect on the CAH community, which stems from concern that DSD contributes to 
stigmatizing CAH and implies some sort of “sexual disorder” in the population labeled as 
having it. Furthermore, there is concern that classifying CAH as a DSD lessens the 
significance of the important medical issues surrounding adrenal insufficiency (Lin-Su et al., 
2015). Of the 486 participants who took the survey, the most favored term, endorsed by 
35% of the respondents, was “non-typical genitalia” (Lin-Su et al., 2015). Healthcare 
providers need to refrain from using terms to describe children born with ambiguous 
genitalia that may be viewed by parents as insensitive or stigmatizing and focus more 
directly on the anatomical presentation, possibility of life threatening salt wasting crisis if the 
child does have CAH, and providing reassurance that CAH is manageable and emphasizing 
the many ways the child is normal.  
Parents of daughters with ambiguous genitalia struggle with sharing information 
about their child’s condition with others, not only at birth, but throughout their child’s life 
(Crissman et al., 2011; Sanders et al., 2012). For parents having a child with ambiguous 
genitalia, the decision of whether or not to disclose information and to whom is based on: 
the likelihood of stigmatization, who they felt had a “right” to the information, a personal ease 
with the terminology associated with the affected anatomy, and parents’ perceptions of their  
ability to accurately describe the condition. If parents decide to share information with 
others, they often choose to limit the amount and details due to the fear of stigmatization, 
which can be taxing on the family (Crissman et al., 2011).  
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Parents of both genders described difficulties in how much information to provide to 
individuals in their child’s social life such as family and friends. They explained not wanting 
to “scare” others  about the possibility of adrenal crisis events when the likelihood of them 
occurring is relatively small. For example, determining if injection training is needed for 
adults watching their child for an occasional, brief period of time was problematic as was 
apprising their child’s adolescent friends of condition management. However, fear that not 
informing others might result in a life threatening situation if their child became ill or 
sustained a traumatic injury was also distressing. Despite these concerns, parents of boys 
did not describe concerns about stigma surrounding disclosure decisions, unlike parents of 
girls. As in previous studies, the parents in this current study guarded the knowledge that 
their daughter was born with ambiguous genitalia very closely in an effort to protect their 
child’s relationships now and in the future and shield them from potential embarrassment 
and stigmatization (Sanders et al., 2012). However, in doing so, parents worried that 
keeping this part of their child’s life a secret was, in and of itself, stigmatizing.  
For families of girls with CAH considering feminizing genitoplasty, perceptions of 
stigma were described as a major factor in parental surgical decision making. If the degree 
of virilization is less, meaning minimal clitoromegaly with the junction between the vagina 
and urethra near the perineum, surgery might not be necessary. However, parents may still 
opt for surgical intervention from a more cosmetic perspective (Speiser et al., 2010). Parents 
are typically told that if they opt for surgery, it is best to do so between two months to one 
year of age due to the assumed child psychological benefits associated with having normal 
genitalia, less likelihood of associated stigma related to ambiguous genitalia, and the 
inability for the child to remember the surgery as a traumatic childhood event (Gollu et al., 
2007). Early surgery is also thought to reduce parental anxiety associated with having a 
child with a disorder of sex development (DSD) (Crawford, Warne, Grover, Southwell & 
Hutson, 2009).  
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However, any type of surgery that reduces clitoral size is a delicate one, as without 
preservation of the neurovascular bundle, the glans, and the preputial skin associated with 
the glans, sensitivity in the genital area may be comprised, which has the potential to 
permanently affect sexual satisfaction in adulthood (Gollu et al., 2007). Additionally, some of 
these girls will need additional, corrective surgery as they age into adulthood in order to 
successfully wear tampons and have sexual intercourse. Having repeated clitoral surgery 
has the potential to cause increased damage to sexual functioning and some providers 
recommend waiting to make the decision to have surgery until the child is old enough to 
participate in the decision making process (Gollu et al., 2007; Creighton, Minto & Steele, 
2001). Certain studies on adult women who have had cosmetic surgery for genital ambiguity 
as children report feeling dissatisfied with having had the surgery, not necessarily related to 
ultimate cosmetic appearance, but rather sexual satisfaction (Gollu et al., 2007; Creighton, 
Minto & Steele, 2001; Rangecroft, 2003). Parents of daughters with ambiguous genitalia 
report a struggle between wanting to protect their child and do “what is right,” but realizing 
that their decision for their child may be in conflict with what their child as an adolescent or 
adult may have chosen for themselves (Carter & Goodacre, 2012). It is evident in this study 
and others that the decision regarding whether or not their daughters should have 
corrective, genital surgery is a very difficult one for parents, filled with concerns over 
stigmatization, future sexual satisfaction, and gender identity (Sanders et al., 2012; 
Crissman et al., 2011; Lundberg et al., 2016). Health care providers must be aware of this 
significant family struggle from social, ethical, and practical perspectives and provide not just 
informative, but also compassionate and supportive, care to families having a daughter with 
CAH. Additionally, this care should not just be focused on the time surrounding the surgery 
and the eventual surgical decision. Thoughtful care should continue throughout the child’s 
life, as early surgical intervention may alleviate some concerns surrounding genital 
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appearance initially, but over time, parents continue to worry about their child’s future sex 
development and function as well as whether additional surgeries will be needed. 
Conclusion 
Although there were some limitations to this study including a small sample size and 
that the children’s perspectives were not included, it is evident that family management is 
different, and more complex, for families of girls when compared to boys with CAH. 
Acknowledging the significant different experiences for families having a boy versus families 
having a girl with CAH and creating support systems specifically for girls born with CAH that 
address both the surgical procedures often associated with ambiguous genitalia  as well as 
possible long-term complications resulting from being born with elevated testosterone is 
critical to promoting a healthy family response and child adaptation to the disorder. 
Healthcare providers, especially pediatric endocrinologists and pediatric endocrine nurses, 
need to evaluate not only the physical aspects of health for girls with CAH such as growth 
and endocrine lab values, but also the psychosocial effects related to being born with 
ambiguous genitalia. Conducting further research into the possible relationship between 
parents of girls deciding to keep the condition confidential in an effort to protect the child and 
family’s privacy and the risk of people in the child’s social environment not knowing of the 
diagnosis, thus not responding appropriately during times of acute illness and/or adrenal 
crisis, is warranted. In summation, future studies with an emphasis on family experiences 
and management, including differences between families having a boy versus a girl, would 
enhance the current state of the science and provide a much-needed window into needed 
prospective interventions aimed at improving the lives of all families and children with CAH. 
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 DISCUSSION 
This dissertation sets the stage for a program of research that will contribute to the 
development of evidenced-based, family-centered interventions for children with congenital 
adrenal hyperplasia (CAH). The analysis reported in Chapter 2 synthesized the existing 
literature examining the care and management of children with CAH over the last fifteen 
years. To date, most investigators have addressed health and developmental issues for 
children with CAH and the unique physical and psychosocial challenges for girls with CAH. 
Relatively few studies have examined the contextual factors influencing child wellbeing or 
the family response to having a child with CAH. 
The primary physiological health issues children with CAH face include obesity, short 
stature, vascular abnormalities, feminizing genitoplasty surgery for girls, and potential 
adrenal crisis events. Obesity was found to be a significant problem in children with CAH 
(Volkl, Simm, Beier, & Dorr, 2006; Mendes-dos-Santos et. al, 2011; Cetinkaya & Kara, 2011; 
Moreira et al., 2013). However, decreased height was more difficult to predict. Medes-dos-
Santos et al. (2011) concluded in their cross sectional study that height in children with CAH 
was similar to unaffected children of the same age, yet final height appeared decreased in 
other studies (Bonfig, 2007; Bonfig, Schmidt & Schwartz, 2011). The only intervention study 
found concerning children with CAH was a 2011 study by Lin-Su, Harbison, Lekarev, 
Vogiatzi, and New, which evaluated whether growth hormone (GH) alone or in combination 
with a leutinizing hormone releasing hormone agonist (LHRHa) would improve final height in 
children with CAH. They concluded that specifically for children with CAH experiencing 
precocious puberty and short stature, GH alone or in combination with LHRHa is an 
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effective therapy for improving final height; however, males experienced somewhat less 
height benefit than females.  
Due to a variety of factors, children with CAH are at risk for vascular problems 
(Harrington, Pena, Gent, Hirte, & Couper, 2012). A 2012 study showed that children with 
CAH have significant vascular and smooth muscle dysfunction when compared to healthy 
controls, and this level of dysfunction was comparable to the healthy subjects that were mild 
to moderately obese, suggesting that it may be obesity rather than adrenal insufficiency that 
places these children at risk. However, more research is needed to evaluate if other risk 
factors such as insulin resistance, hypertension, dyslipidemia, hypercortisolism, and 
hyperandrogenism play a role in reduced vascular function (Harrington et al., 2012).  
Very few studies focused on acute illness, stress dosing, and adrenal crisis 
prevention, despite the fact that parents in the current study expressed much concern about 
these events. Three of the four studies investigating illness and adrenal crisis examined the 
role that physical stress had on glucose regulation in children with CAH. Children with CAH 
do not mount the normal exercise-induced glucose response due to lack of cortisol 
production with physical activity (Weise et al., 2004; Green-Golan et al., 2007) and are at 
risk for hypoglycemia during acute viral or bacterial illnesses (Keil, Bosmans, Van Ryzin & 
Merke, 2010). These studies suggest the need for additional glucose supplementation in 
addition to “stress dosing” during times of acute illness (Keil et al., 2010) as well as possibly 
before strenuous exercise (Weise et al., 2004; Green-Golan et al., 2007). A 2011 study by 
the author investigated parents’ knowledge of CAH, adrenal crisis, and stress dosing as well 
as their confidence in responding to adrenal crises (Fleming, Rapp & Sloane, 2011). As with 
this dissertation study, parents stated that their children experience adrenal crisis events an 
average of one to two times per year and described having a clear understanding of the 
condition and the need for stress dosing/injection; however, they felt that there was a lack of 
repeated instruction and demonstrations from providers on how to give the injection 
	
	
	 99 
Fleming, Rapp & Sloane, 2011. Parental difficulties in effective and detailed communication 
with their CAH child’s health care providers, especially surrounding the time of diagnosis 
and in adrenal crisis management, were found in this study as well as a 2014 study (Boyse 
et al.).  
The studies that explored health related quality of life (HRQoL) for children with CAH 
had mixed results. Parents in the Netherlands reported no negative effects on their child’s 
quality of life (Sanches et. al, 2012); however a Brazilian study (Gilban, Alves and Beserra, 
2014) found a loss of HRQoL in children and teens with CAH, especially in the physical 
dimension (when compared with unaffected controls), and a study based of out Los Angeles 
(Yau et al., 2015) found that children with CAH had an overall decrease in HRQoL with 
regard to school functioning.  
The majority of the studies found in the systematic review concerned the 
consequences of androgen exposure on child behavior in girls born with CAH, not surgical 
decision making by parents, nor possible stigma associated with being born with ambiguous 
genitalia. Although reconstructive feminizing genitoplasty is recommended by some 
providers at an early age and can involve multiple surgeries into adolescence (Witchel & 
Azziz, 2011; Karkazis, 2008), there is not an accepted recommendation by providers on this 
issue. Girls with CAH identify as female (Berenbaum & Bailey, 2003; Dessens, Slijper, & 
Drop, 2005), but they often show increased preference for male toys and activities 
(Nordenstrom et al., 2002; Pasterski et al, 2005; Wong et al., 2013), increased aggression 
(Pasterski et al., 2007; Mathews et al, 2009), increased male-typical sexual orientation 
(Nordenstrom et al., 2010), and differences when compared to non-CAH girls in spatial 
abilities (Hines et al., 2003; Berenbaum et al., 2012). 
In the systematic review, it is evident that more research examining CAH from a 
family perspective as well as different research methodologies is needed to better 
understand the challenges these families face so that interventions can be developed to 
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improve their daily lives. The studies reviewed used quantitative methods for the most part 
and were cross-sectional and descriptive in nature. Additionally the studies that used 
structured measures did not report their reliability and validity. Since these studies focused 
on children, the lack of longitudinal studies is a notable gap in the literature. Moreover, there 
are few qualitative or mixed method studies on the issue of how families are coping with 
having a child with CAH, which is surprising as ambiguous genitalia and the life threatening 
nature of CAH along with the related physical and emotional struggles are sensitive topics 
that are likely difficult to adequately address in questionnaires and surveys.  
Chapter 3 of this dissertation comprised the primary, mixed methods study that 
investigated parental management of adrenal crisis in children with CAH. This study had 
findings that point to a clear and distinct need for increased healthcare provider education 
related to supporting parents of children having CAH. The most important findings from the 
analysis of Phase 1 include that 25% of parents surveyed did not receive the prescription for 
injectable hydrocortisone within one month of diagnosis, despite that being the standard of 
care (Speiser et al., 2010). Additionally, there were significant relationships between parents 
having directly been shown by a provider how to correctly administer the injection and a 
stronger perceived ability to manage the condition as well as between the age of child and 
the average number of adrenal crisis events experienced each year, with the number of 
crises decreasing over time. Regarding frequency of adrenal crisis events, parents reported 
children having 0.77 adrenal crisis events per year (a minimum number of 1 adrenal crisis 
episode every 1.3 years) in the first five years of life; after the age of five, parents reported 
0.27 adrenal crisis events per year (a minimum of 1 adrenal crisis episode every 3.7 years). 
Moreover, there was a significant, positive relationship between the age of the child and 
perceived management ability by parents. Finally, there was a significant, negative 
relationship between perceived management ability by parents and the impact CAH has on 
the family. 
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In Phase two of the study, it was evident that there are multiple contextual influences 
that affect family management of CAH including interchanges with schools and healthcare 
providers, the child and family’s social network (extended family, sports and extracurricular 
activities, babysitters), and access to resources. One half of the parents interviewed (five 
families) switched healthcare providers within the first two years of their child’s life due to a 
perceived lack of provider knowledge of CAH treatment and/or lack of provider education on 
adrenal crisis management. Furthermore, parents don’t feel they have received frequent 
enough instruction from health care providers on how to administer intramuscular 
hydrocortisone and would benefit from repeated demonstrations. In addition, parents don’t 
feel they receive meaningful emotional support from their child’s healthcare providers. 
Despite the challenges associated with the condition, all of the parents interviewed felt 
day-to-day management of their child’s condition is going very well and that their children 
are thriving overall. Partnered parents did not express any discrepant views of the illness, 
nor any significant tension in their relationship related to their child’s CAH; however, parents 
did express some differences in management of the condition. One example is how quickly 
a parent decides to stress dose with steroids when their child is ill. 
Parents of children with CAH feel a pervasive worry about possible adrenal crisis 
events, their CAH child’s transition into young adulthood/adolescence and “letting go,” and 
the experiences for siblings of watching the CAH child have an adrenal crisis and witnessing 
the extra attention the CAH child requires. Additionally, because CAH is autosomal 
recessive, future family planning decisions are challenging for these families  
Chapter 4 examined the differences in management experiences for families having 
a girl with CAH versus families having a boy. The time period surrounding the child’s 
diagnosis and the consequences of ambiguous genitalia including the related fear or actual 
stigmatization, who to disclose the situation to, and the often necessary difficult surgical 
decisions parents must make show the unique, additional struggles families having a girl 
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with CAH face. Acknowledging these important differences and how these differences affect 
the family is crucial. Support systems specifically for girls born with CAH that address both 
the surgical procedures often associated with ambiguous genitalia as well as possible long-
term complications resulting from being born with elevated testosterone is needed and 
should be encouraged by health care providers. Additionally, pediatric endocrinologists and 
pediatric endocrine nurses need to asses both the physical health for girls with CAH as well 
as the emotional aspects related to being born with ambiguous genitalia and make referrals 
as need to mental health professionals equipped to handle these concerns.  
Future Implications for Practice and Research 
There is a clear need for additional research to identify the ways in which having a 
child with CAH intersects with family life. From a research methodology perspective, 
additional studies that are longitudinal in nature, have a larger number of participants, and 
are qualitative or use mixed methods would be beneficial in providing a richer and more 
meaningful understanding family management challenges over time.  
Additionally, intervention studies addressing parental knowledge of effective 
response to adrenal crisis events are warranted. The problem of ineffective preparation 
regarding how to manage an adrenal crisis for parents of children with CAH by providers is 
likely multi-factorial. Limited time during the provider-patient encounter, the episodic nature 
of adrenal crises, and necessity to discuss management issues such as lab values, growth, 
and weight rather than crisis management may be the focus in encounters with providers. 
During routine office visits, health care professionals may not recognize the importance of 
emergency management and assessing parents’ current level of competency. Although 
parents of children with CAH must deal with aspects of the disease other than adrenal crisis, 
it is the life threatening aspect of the disorder that is the focal concern identified by parents 
based on the results of both the current study and others (Merke & Bornstein, 2005; 
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Fleming, Rapp, & Sloane, 2011). When parents are not properly educated on how to 
respond to adrenal crisis events, the result can lead to parental stress as well as serious 
injury and possible death of the child. An intervention study addressing these gaps in 
provider education is critical. One such intervention could include the use of a training video 
that discusses the condition and walks through the injection process in detail, with the 
intervention involving parental review of the video at six-month intervals coinciding with their 
child’s required lab draws. This video could also be used by parents to train others who care 
for their children in the parents’ absence, such as babysitters and teachers.  
From this study, it appears there is room for improvement in the interactions between 
pediatric endocrinologists and parents, especially surrounding parental adrenal crisis 
preparation and the potential stigma associated with ambiguous genitalia. Studies that 
investigate how pediatric endocrinologists view adrenal crisis events themselves might be 
helpful in addressing the disconnect parents feel regarding a lack of thorough, detailed 
provider instruction on adrenal crisis management. Perhaps pediatric endocrinologists have 
not witnessed these crisis events firsthand, as by the time they are likely notified, many of 
the children experiencing adrenal crisis have been stabilized post-injection, either in their 
homes or in the emergency departments. The lack of provider involvement in the actual 
adrenal crisis event might account for some of the decreased emphasis placed on parental 
preparation.  
Moreover, pediatric endocrinologists are in a challenging position regarding long 
term care of ambiguous genitalia, both for their female CAH patients that have had 
corrective surgery as well as those that have not. Stigmatization, repeated genital surgeries, 
and sexual satisfaction are sensitive topics, especially during adolescence. It is likely that 
these children and their parents are interacting more regularly over the course of childhood 
with a pediatric endocrinologist, rather than a surgeon, and perhaps frequent guidance and 
discussion of these complex topics from pediatric endocrinologists would be beneficial for 
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families. For example, the relationship between parents of girls deciding to keep the 
condition confidential in an effort to protect the child and family’s privacy and the risk of 
people in the child’s social environment not knowing of the diagnosis, thus not responding 
appropriately during times of acute illness and/or adrenal crisis, warrants addressing.  
Finally, hearing from children with CAH themselves would be helpful in 
understanding the individual, as well as the family, effects of this episodically life threatening 
condition. Such a study would need to include both boys and girls with the condition as well 
as children that are varied ages, as the experience and concerns of a younger child is likely 
significantly different from an adolescent, especially with regards to social support. 
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APPENDIX A: INVITATION TO PARTICIPATE LETTER 
“Parents Managing Adrenal Crisis in Children with Congenital Adrenal Hyperplasia” 
We are inviting you to take part in a research project that we are conducting with parents (or 
primary caregivers) of children with classic congenital adrenal hyperplasia (CAH).  The 
purpose of this study is to better understand how parents view and manage adrenal crisis 
episodes in their children with CAH. Additionally, how parents are prepared by health care 
providers on managing their child’s adrenal crisis and the impact on the family of having a 
child with a life threatening condition will be explored. 
Who can participate? If you are the parent of a child with classic CAH age 0-18, you are 
invited to participate. Your child must not have any other complex medical conditions. If your 
child is not between the ages of 0-18 or has additional complex medical conditions, you are 
not eligible for this study at this time. In addition, you must speak English, be at least 18 
years old, have an email account, and have access to the internet. Please contact Louise 
Fleming at lkflemin@email.unc.edu with any questions. 
What will we ask you to do? We will ask you to complete four online questionnaires, and 
may interview you, if you are willing. The questionnaires include one with general family 
information (such as where you live, how old your child(ren) is, etc.) as well as the Family 
Management Measure (FaMM)-View of Condition Impact scale, which has 10 items; the 
FaMM Management Ability Scale, which as 12 items; and the PedsQL-Family Impact 
Module, which has 36 items. They will measure the impact that you feel your child’s CAH 
has on your family, how well you feel you manage your child’s CAH, and they should take 
about 15-20 minutes to complete. The interview will be a telephone interview at a time that 
is convenient for you. The interview will take approximately 45-60 minutes.  
 
The project has been approved institutional review board for human subjects research at 
University of North Carolina at Chapel Hill and is supported by the CARES Foundation. If 
you agree to take part, all information you give will be confidential. No one except the 
research team, which includes the chair of my dissertation committee, Marcia Van Riper, 
PhD, RN, FAAN, will have access to your information.If you wish to be involved in this 
research or have any questions, please contact Louise Fleming. Email is 
lkflemin@email.unc.edu or telephone (919) 272-7174. Many thanks for your kind 
consideration. 
 
Louise 
Louise K. Fleming, PhD(c), MSN, RN 
UNC School of Nursing 
307G Carrington Hall 
Campus Box 7460 
Chapel Hill, NC 27599-7460 
lkflemin@email.unc.edu  
C 919.272.7174 
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APPENDIX B: INTERVIEW GUIDE 
Opening: 
 
I would like to thank you for taking the time to talk to me about your child’s CAH and how 
you (and partner, spouse, etc. if applicable) manage the condition, especially during times of 
adrenal crisis. The questions I will ask are to learn how you (and your partner) feel about the 
preparation you have received regarding how to handle times of adrenal crisis, how such 
information was given to you by providers, and how you then prepare others that care for 
your child, when you are not present, to handle possible crises. Additionally, I will ask you 
some questions about how having child with a life-threatening condition have affected you 
and your family, if at all.  
 
If I will also be, or have already interviewed your partner, please know that both of your 
responses will be kept confidential. I will not share what you say with them, or what they say 
with you.  
 
Definition of the Situation: 
 
Tell me how you felt soon after your child was diagnosed with CAH and has that changed in 
the [XX] years since diagnosis? 
 
How would you describe your child’s day and typical activities in comparison to other 
children his (or her) age?  
 
How much would you say you and your partner have in common with how you view and 
manage your child’s CAH?”  
 
Tell me about how confident you feel to take care of your child’s CAH. 
 
If you were to make support group topics for families of children with CAH, what do you think 
would be most important to discuss? 
 
 
Management Behavior : 
 
Tell me about some of the aspects of managing the life threatening components of your 
child’s condition that you believe are going well. 
 
Tell me about how your provider has prepared you, if at all, to handle a potential adrenal 
crisis and are you satisfied with the instruction? Have you sought such instruction from 
sources other than your child’s healthcare providers such as the internet or support groups, 
and if so, tell me to what extent you have found that to be helpful. 
 
Who in your social network, such as schools, babysitters, family members, etc., have you 
discussed your child’s CAH with and how, if at all, have you prepared them to care for your 
child if an adrenal crisis episode were to occur when you are not present?  
 
Perceived Consequences:  
 
Tell me how many times a day you think about your child’s CAH. 
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How would you describe the impact of the life threatening nature of CAH on day-to-day 
family life?  
 
How do you see CAH impacting your child and family in the future? 
 
If your child with CAH has siblings, what impact, if at all, do you consider having a brother 
(or sister) with CAH has on them? 
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APPENDIX C: FAMILY INFORMATION FORM 
Family Information Form--Parental Management of Adrenal Crisis in Children with 
Classical Congenital Adrenal Hyperplasia (CAH) 
 
We are interested in finding out more information about the care of your child with classic CAH and 
your family as well as your experiences with adrenal crisis. These questionnaires should only take 
approximately 20 minutes to complete. Your answers will be combined with those of other parents. 
Please answer the questions to the best of your knowledge and remember that the answers to this 
survey are confidential. Thank you. 
 
I understand that by completing these surveys, I consent to participate in this study. 
  
If you are interested in being interviewed please check yes. The interview will be conducted at 
a time and time or your choice. Yes___ No____ 
 
If you choose Yes to be potentially being interviewed, please provide your first name, child’s 
first name, your relationship to the child with CAH, and your preferred contact information 
(phone number, email address, etc.). Depending on the number of willing participants, there is 
the possibility that not every parent willing to participate in an interview will be asked to 
participate in one.  
 
 
This survey is intended for caregivers/parents/guardians of children between the ages of birth-18 
years of age with classic (salt-wasting) CAH only. 
 
1.  Is your child between the ages of 0-18 years of age? ____ Yes_____No  
 
2. Does your child have classic (salt-wasting) Congenital Adrenal Hyperplasia (CAH)?_____ 
Yes_____No  
 
3. Does your child have any other complex medical conditions? ______Yes_____No 
 
4. To the best of your knowledge, how often does your child have an adrenal crisis? 
______________________________________________________________________ 
5. Do you have a prescription for injectable hydrocortisone (also known as Solu-Cortef)?  
If No, check here ______and go to question 7 on the bottom of this page.  If yes, please answer the 
questions 6a-6h below. 
 
6a. Have you filled the prescription? _____Yes_____No 
 
6b. How long after your child’s diagnosis did you receive the prescription for injectable 
hydrocortisone? _____at diagnosis or_________days/month/years (circle correct length). 
 
6c. Which statement best fits how you got your child’s prescription for injectable hydrocortisone: 
My doctor prescribed it at diagnosis without me saying anything_____ 
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Sometime after diagnosis I had to ask my child’s physician for the prescription of 
injectable hydrocortisone_____ or  
My physician prescribed injectable hydrocortisone for my child eventually without my 
asking for it_____ 
 
6d. Did you change physicians in order to receive the prescription for injectable hydrocortisone? 
_____Yes_____No 
 
6e. Does your child consistently have a vial of injectable hydrocortisone readily available for an 
emergency? (for example, at their school, in the home, at daycare, in the car, etc.) 
_____Yes_____No 
 
6f. Have you ever given your child a shot of injectable hydrocortisone?  _____Yes_____No 
 
6g.Do you have a written instruction guideline sheet for stress-dosing during adrenal crisis via an 
injection that was given to you by your physician?     _____Yes_____No.  
If you answered yes, please check all information that is listed on the instruction sheet: 
 _____dose of injectable hydrocortisone 
 _____under what circumstances to give the injection 
 _____how and where to give the injection 
 
6h. Has your physician OR one of his/her staff (such as a nurse or medical assistant) ever 
demonstrated to you how to correctly administer a shot of injectable hydrocortisone to your child? 
_____Yes_____No 
Go to Question 7 
 
7.   Does your child wear a medical identification tag specifying that he/she has CAH or is adrenal 
insufficient?   _____Yes_____No  
 
8. Does your child see a pediatric endocrinologist to manage and treat his/her  
CAH?_____Yes_____No.  
If no, what type of healthcare provider treats your child’s CAH? 
__________________________________________(ex. general pediatrician, family practice 
physician, nurse practitioner, etc). 
8a. Is the health care provider who manages and treats your child’s CAH affiliated with a 
medical school?_____Yes_____No 
 
Please list the medications your child is currently taking: 
______________________________________________________________________ 
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______________________________________________________________________ 
9.  Parent gender:   ______M   ______F 
 
10.  Parent age:    ________ 
 
11.  Gender of child with CAH:   ______M   ______F 
 
12.  Age of child with CAH:  _____years_____months 
 
13. Race of you and your child (ex. American Indian, Asian, Native Hawaiian, Black/African American, 
White, other-please specify): You______________ Your Child___________ 
 
14. Ethnicity of you and your child (Hispanic/Latino or Not Hispanic/Latino):  
You   _________ Your Child___________  
 
15. Please list all family members that live in your home. Simply list their relationship to your child 
with CAH, their age, and their gender. Example: 5 year old sister. No names are necessary. 
 
 
 
______________________________________________________________________ 
 
16. Family Type: 
 ________2 parent family 
 ________Single parent family (only mother) 
 ________Single parent family (only father) 
 ________Single parent family (mother figure only) living with partner 
 ________Single parent family (father figure only) living with partner 
 ________Other relative(s) 
 ________Foster family 
 ________Other: please specify ____________________________ 
 
17. Approximate gross yearly family income (before taxes): 
__ Less than $20,000  __ $60,000 to $69,999 
__ $20,000 to $29,999 __ $70,000 to $79,999 
__ $30,000 to $39,999 __ $80,000 to $89,999 
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__ $40,000 to $49,999   __ $90,000 to $99,999 
__ $50,000 to $59,999 __ Over $100,000 
18. What city and state do you live in?________ 
 
19. Approximately how many hours do you travel to see the physician who currently manages and 
treats your child’s CAH?_____ 
 
20. How far from your home is the hospital where you would take your child if he/she were in adrenal 
crisis?______________________ 
 
Thank you very much for your time. 
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APPENDIX D: PEDIATRIC QUALITY OF LIFE-FAMILY IMPACT MODULE 
For each statement in this questionnaire, you are asked to rate your response 
to the statement on a scale of 0 to 4, with 0 indicating “Never,” 1 indicating 
“Almost Never,” 2 indicating “Sometimes,” 3 indicating “Often,” and 4 
indicating “Almost Always”.  Please respond to each statement in this 
questionnaire based on what you think, not on how you think others might 
respond. 
 
DIRECTIONS: In the past ONE MONTH, as a result of your child’s health, how 
much of a problem have YOU had with…. 
 
PHYSICAL FUNCTIONING 
(problems with…) 
Never Almost 
Never 
Sometimes Often Almost 
Always 
1. I feel tired during the 
day 
0 1 2 3 4 
2. I feel tired when I 
wake up in the 
morning 
0 1 2 3 4 
3. I feel too tired to do 
the things I like to do 
0 1 2 3 4 
4. I get headaches 0 1 2 3 4 
5. I feel physically weak 0 1 2 3 4 
6. I feel sick to my 
stomach 
0 1 2 3 4 
 
EMOTIONAL FUNCTIONING 
(problems with…) 
Never Almost 
Never 
Sometimes Often Almost 
Always 
1. I feel anxious 0 1 2 3 4 
2. I feel sad 0 1 2 3 4 
3. I feel angry 0 1 2 3 4 
4. I feel frustrated 0 1 2 3 4 
5. I feel helpless or 
hopeless 
0 1 2 3 4 
 
SOCIAL FUNCTIONING 
(problems with…) 
Never Almost 
Never 
Sometimes Often Almost 
Always 
1. I feel isolated from 
others 
0 1 2 3 4 
2. I have trouble getting 
support from others 
0 1 2 3 4 
3. It is hard to find time 
for social activities 
0 1 2 3 4 
4. I do not have enough 
energy for social 
activities 
0 1 2 3 4 
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COGNITIVE FUNCTIONING 
(problems with…) 
Never Almost 
Never 
Sometimes Often Almost 
Always 
1. It is hard for me to 
keep my attention on 
things 
0 1 2 3 4 
2. It is hard for me to 
remember what 
people tell me 
0 1 2 3 4 
3. It is hard for me to 
remember what I just 
heard 
0 1 2 3 4 
4. It is hard for me to 
think quickly 
0 1 2 3 4 
5. I have trouble 
remembering what I 
was just thinking 
0 1 2 3 4 
 
COMMUNICATION (problems 
with…) 
Never Almost 
Never 
Sometimes Often Almost 
Always 
1. I feel that others do 
not understand my 
family’s situation 
0 1 2 3 4 
2. It is hard for me to talk 
about my child’s 
health with others 
0 1 2 3 4 
3. It is hard for me to tell 
doctors and nurses 
how I feel 
0 1 2 3 4 
 
WORRY (problems with…) Never Almost 
Never 
Sometimes Often Almost 
Always 
1. I worry about whether or 
not my child’s medical 
treatments are working 
0 1 2 3 4 
2. I worry about the side 
effects of my child’s 
medications/treatments 
0 1 2 3 4 
3. I worry about how 
others will react to my 
child’s condition 
0 1 2 3 4 
4. I worry about how my 
child’s illness is 
affecting other family 
members 
0 1 2 3 4 
5. I worry about my child’s 
future 
0 1 2 3 4 
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DIRECTIONS: Below is a list of things that might be a problem for your family. Please tell 
us how much of a problem each on has been for your family during the past ONE 
month. 
 
DAILY ACTIVITIES (problems 
with…) 
Never Almost 
Never 
Sometimes Often Almost 
Always 
1. Family activities taking 
more time and effort 
0 1 2 3 4 
2. Difficulty finding time 
to finish household 
tasks 
0 1 2 3 4 
3. Feeling too tired to 
finish household tasks 
0 1 2 3 4 
 
FAMILY RELATIONSHIPS 
(problems with…) 
Never Almost 
Never 
Sometimes Often Almost 
Always 
1. Lack of 
communication 
between family 
members 
0 1 2 3 4 
2. Conflicts between 
family members 
0 1 2 3 4 
3. Difficulty making 
decisions together as 
a family 
0 1 2 3 4 
4. Difficulty solving family 
problems together 
0 1 2 3 4 
5. Stress or tension 
between family 
members 
0 1 2 3 4 
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APPENDIX E: FAMILY MANAGEMENT MEASURE-VIEW OF CONDITION IMPACT 
SCALE 
This questionnaire is about how your family manages caring for a child with a 
chronic condition, and for this study, the condition is congenital adrenal 
hyperplasia (CAH).  
 
DIRECTIONS: 
For each statement in this questionnaire, you are asked to rate your response 
to the statement on a scale of 1 to 5, with 1 indicating “Strongly Disagree” and 
5 indicating “Strongly Agree”.  Please respond to each statement in this 
questionnaire based on what you think, not on how you think others might 
respond. Many of these questions use the word “family”.  This refers to those 
people living in your household who you think of as family. 
 
Please check the boxes with your answers.  
 
 
Strongly 
Disagree 
1 
 
 
2 
 
 
 
3 
 
 
 
4 
Strongly 
Agree 
5 
1.  Our child’s condition is the 
most important thing in our 
family.  
     
2.  Because of the condition, we 
worry about our child’s 
future.  
     
3.  We expect to be devoting 
less time to our child’s 
condition in the future.  
     
4.  Our child’s condition requires 
frequent hospital stays.      
5.  People with our child’s 
condition have a normal 
length of life.  
     
6.  Our child’s condition will be 
harder to take care of in the 
future.  
     
7.  We think about the way our 
child’s condition all the time.       
8.  Many conditions are more      
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Strongly 
Disagree 
1 
 
 
2 
 
 
 
3 
 
 
 
4 
Strongly 
Agree 
5 
serious than the ones our 
child has.  
9.  It is hard to know what to 
expect of our child’s 
condition in the future.  
     
10.  We are confident that we 
can take care of our child’s 
condition.  
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APPENDIX F: FAMILY MANAGEMENT MEASURE-MANAGEMENT ABILITY SCALE 
This questionnaire is about how your family manages caring for a child with a 
chronic condition, and for this study, the condition is congenital adrenal 
hyperplasia (CAH).  
 
DIRECTIONS: 
For each statement in this questionnaire, you are asked to rate your response 
to the statement on a scale of 1 to 5, with 1 indicating “Strongly Disagree” and 
5 indicating “Strongly Agree”.  Please respond to each statement in this 
questionnaire based on what you think, not on how you think others might 
respond. Many of these questions use the word “family”.  This refers to those 
people living in your household who you think of as family. 
 
Please check the boxes with your answers.  
 
 
Strongly 
Disagree 
1 
 
 
2 
 
 
 
3 
 
 
 
4 
Strongly 
Agree 
5 
1.  In the future, we expect our 
child to take care of the 
condition.  
     
2.  We have some definite ideas 
about how to help our child 
live with the condition.  
     
3.  Despite the condition, we 
expect our child to live away 
from home in the future.  
     
4.  We have enough money to 
manage our child’s condition.      
5.  We are looking forward to a 
happy future for our child.       
6.  When something unexpected 
happens with our child’s 
condition, we usually know 
how to handle it.  
     
7.  We feel we are doing a good 
job taking care of our child’s 
condition.  
     
8.   We have goals in mind to      
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Strongly 
Disagree 
1 
 
 
2 
 
 
 
3 
 
 
 
4 
Strongly 
Agree 
5 
help us manage our child’s 
condition.  
 
9.   It is difficult to know when our     
      child’s condition must come  
      first in our family. 
 
     
10.  It is often difficult to know if 
we need to be more 
protective of our child 
     
11.  We often feel unsure about 
what to do to take care of our 
child’s condition. 
     
12.  We have not been able to 
develop a routine for taking 
care of our child’s condition.  
     
 
 
 
